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This study aimed to test the efficacy of a brief intervention for the prevention of 
depression among at-risk college students. Treatment group participants attended a 
one-hour psychoeducational session based on an acute group-based intervention for 
depression, Therapeutic Lifestyle Change (TLC; Ilardi et al., 2009). Participants were 
informed of a set of six modifiable lifestyle factors (omega-3 supplementation, social 
support, physical exercise, sunlight exposure, healthy sleep, and anti-rumination 
strategies) which have shown promise in the treatment and prevention of depression 
(Karwoski, 2006). Treatment group participants evidenced a significant increase in 
adherence to three of the six targeted TLC elements: supplementing with fish oil, 
obtaining adequate sleep, and utilizing social support. However, there were no 
observed between-group differences in self-reported depression symptoms, as 
reflected in the BDI-II, at either follow-up assessment. Nevertheless, as hypothesized, 
study participants who received the TLC-based intervention were significantly less 
likely than were control participants to report the experience of a depressive episode 
at two- and six-month follow-ups.  The intervention appears, therefore, to have 
reduced the risk of depression onset in a high-risk population, although some 





THERAPEUTIC LIFESTYLE CHANGE: A BRIEF PSYCHOEDUCATIONAL 
INTERVENTION FOR THE PREVENTION OF DEPRESSION 
Major depressive disorder (MDD) is a debilitating clinical syndrome that now 
afflicts nearly one in four Americans by age 75 (Kessler et al., 2005). The disorder is 
characterized by severe functional impairment and attenuated quality-of-life (Üstün, 
2001), and depressed patients spend more cumulative time in bed than do those with 
arthritis, diabetes, or even lung disease (Wells, Sturm, Sherbourne, & Meredith, 
1996). The total cost of major depression – in the form of both lost productivity and 
direct treatment – amounts to over $83 billion dollars each year in the U.S. alone 
(Greenberg et al., 2003). In fact, it is now projected that within a decade MDD will 
become the second most costly disease worldwide in terms of ill health and premature 
death (Murray & Lopez, 1998). 
Depression is also a highly recurrent illness, with up to 85% of afflicted 
individuals experiencing a clinical course marked by alternating periods of recovery 
and remission (Coyne, Pepper, & Flynn, 1999). Over a lifetime, the typical clinically 
depressed patient will experience four to five major episodes, each lasting an average 
of 20 weeks (Judd, 1997; Gotlib & Hammen, 1992). And this recurrent pattern entails 
serious consequences. Each successive depressive episode is commonly characterized 
by increased duration (Coryell, Endicott, & Keller, 1990) and severity of 
symptomatology (Maj, Veltro, Pirozzi, Lobrace, & Magliano, 1992). 
Although there exists a large body of empirical research on both risk factors 




which such knowledge can be translated into effective preventive interventions 
(Paykel, 2006). Only in recent years have researchers begun to make the prevention 
of depression a principal focus of investigation, and research in this area still lags far 
behind that pertaining to acute treatment (Le & Boyd, 2006). Indeed, depression 
prophylaxis has remained something of an esoteric subfield that has been difficult to 
integrate into clinical practice (Cardemil & Barber, 2001; Muñoz & Ying, 1993). 
However, increasing awareness of the cascading effect of recurrent depression has 
catalyzed an increased effort both to identify effective methods of preventing relapse 
(Hart, Craighead, & Craighead, 2001) and to help vulnerable individuals avert the 
downward clinical spiral of successive episodes. 
Importance of Prevention 
The amelioration of illness via acute treatment is an important clinical aim, 
but the prevention of illness by means of effective proactive intervention is arguably 
even more so. In fact, the focus of 21st century medicine is increasingly shifting to the 
conservation of health rather than the treatment of disease, per se (Monclús, 2003). 
Prevention appears to be especially important in the case of depression, inasmuch as 
people with MDD are among the least likely of those suffering from any form of 
mental illness to seek and receive treatment for their distress. Even among depressed 
individuals with severe manifestations of mental illness – i.e., a lifetime history of 
three or more comorbid disorders – the proportion obtaining adequate treatment for 




professional help may be due in part to negative cultural or personal attributions 
(Han, Chen, Hwang, & Wei, 2006). 
Type of Prevention 
Traditional definitions of prevention classify intervention efforts into three 
distinct groups: (a) primary prevention programs that intervene with an entire 
population to prevent new cases of a disorder, (b) secondary prevention programs that 
focus on groups at risk, and (c) tertiary prevention programs that focus on 
maintenance of health and relapse prevention for individuals who have already 
developed a disorder (Commission on Chronic Illness, 1957). Secondary prevention 
is often considered the most feasible and cost-effective approach because the targeted 
population is circumscribed and easily identified (Murray, 1995). In many cases, the 
differentiation between secondary and tertiary prevention is more implied than real; 
secondary prevention can legitimately focus on individuals who have experienced a 
previous episode but are in full remission (Ingram et al., 2004), given that past 
depression is the best predictor of future depression (Lewinsohn, Hoberman, & 
Rosenbaum, 1988). 
An alternative, more recent subclassification of prevention efforts 
distinguishes between: (a) universal prevention programs that target the general 
population without identifying at-risk or vulnerable individuals, (b) selective 
prevention programs that target individuals whose risk for the development of a 
disorder is significantly higher than average, and (c) indicated prevention programs 




of a disorder (Mrazek & Haggerty, 1994; Muñoz, Mrazek, & Haggerty, 1996). The 
majority of depression prevention efforts have focused on selective prevention (e.g., 
Bockting et al. 2005; Thase et al., 2001), although a few have focused on indicated 
prevention (e.g., Rapaport & Judd, 1998) or a combination of the two (e.g., Paykel et 
al., 1999). 
Cost-Effectiveness 
Prevention efforts also represent a particularly cost-effective approach to the 
treatment of chronic illnesses like depression, which have become the predominant 
global source of morbidity, death, and disease during the 21st century (McQueen, 
2007). Smit and colleagues (2006), for example, analyzed the cost-effectiveness of a 
successful “minimal-contact” intervention designed to prevent depression among 
subclinically depressed individuals (a population at very high risk for the onset of 
major depressive illness; Gotlib, Lewinsohn, & Seeley, 1995; Horwath, Johnson, 
Klerman, & Weissman, 1992; Pintor, Gastó, Navarro, Torres, & Fañanas, 2001). 
Patients were given a self-help manual with instructions on mood management, which 
was augmented by an in-person interview with a specialist and six short telephone 
calls. The intervention incurred an average cost of approximately $576, but this 
additional cost was fully compensated by savings elsewhere. Over one year, out-of-
pocket health care costs between intervention and control groups yielded an average 
difference of approximately $90 in favor of the intervention. Reduced productivity 
losses (e.g., absences from work) resulted in further savings – an average advantage 




Likewise, Lynch et al. (2005) recently examined the cost-effectiveness of a 
group cognitive-behavioral program designed to prevent depression in the adolescent 
offspring of depressed parents. During the year following the intervention, those who 
received the intervention used significantly fewer healthcare services than did the 
control participants. Such services included a variety of specialty mental health 
services such as family counseling, individual psychotherapy, and outpatient/inpatient 
hospital visits. Further, across seven different categories of service use, the control 
participants used services at a rate 15 times higher than that of intervention 
participants. These findings suggest that the initial cost of depression prevention 
programs may be easily offset by the financial savings post-intervention. 
Traditional Preventive Interventions 
Pharmacotherapy 
There exists a large body of empirical research examining the effectiveness of 
antidepressant medication in the prevention of depression, often as a continuation of 
the medication regimen used to treat acute symptoms. On occasion, antidepressant 
medications are also employed prophylactically with individuals who have never 
experienced clinical depression, inasmuch as such medications carry the potential to 
help prevent the escalation of mild depressive symptoms into full-blown major 
depressive disorder (Ingram, Odom, & Mitchusson, 2004). 
Several different psychotropic medications have been evaluated in 
continuation treatment, which can be extended for many months (or even years) 




Teasdale, 2003). Medications seem to be somewhat useful as preventive measures, 
though perhaps less effective over the long term. For example, Franchini and 
colleagues (Franchini, Zanardi, Gasperini, & Smeraldi, 1999) evaluated citalopram (a 
selective serotonin reuptake inhibitor) as a continuation treatment for 40 recovered 
patients with recurrent depression. Although there were no relapses among the 36 
study patients within the first four months of the study, there was a high rate of 
recurrence (50%) by the study’s two-year follow-up, similar to the rate observed in 
the absence of continued medication. Robert and Montgomery (1995), however, 
evaluated citalopram as a preventive strategy over a six-month period and found a 
somewhat lower relapse rate among patients in the treatment group (13.8%) than 
among patients receiving only pill placebo (24.3%). 
Thase and colleagues (Thase, Nierenberg, Keller, & Panagides, 2001) 
evaluated mirtazapine (an antidepressant that works on noradrenergic, histaminergic, 
and serotonergic receptors) as a maintenance strategy for 156 fully remitted patients. 
Continuing mirtazapine therapy significantly reduced the rate of relapse by a 40-week 
follow-up (19.7% versus 43.9% in the placebo group). Similar reductions in relapse 
risk have been reported in numerous other studies with continuation antidepressants 
among remitted patients (e.g., Feiger et al., 1999; Montgomery, 1999). Accordingly, 
continuation medication as a standard part of clinical care, especially among patients 
with recurrent depression, is now recommended by many clinical researchers (e.g., 




There are, however, numerous potential problems with the use of 
antidepressants as a prevention strategy. First, some patients may not be able to 
tolerate the ongoing difficulties that often characterize the long-term use of 
antidepressants, such as financial strain and an onerous side effect profile (Mago, 
1999; Overholser, 1998). Up to 60% of patients fail to achieve adequate adherence to 
their medication regimens (Lingam & Scott, 2002; Byrne, Regan, & Livingston, 
2006). Second, a large proportion of recovered patients – over half (Franchini et al., 
1999; Solomon et al., 2005) – will relapse despite being maintained on medication. It 
is hypothesized, in fact, that antidepressant medications often lose their effectiveness 
with continued use (Byrne & Rothschild, 1998). Third, although the continued use of 
such medications may suppress symptoms, some believe it fails to address the 
underlying cause(s) of continued vulnerability to depression (Hollon, Shelton, & 
Loosen, 1991). Finally, although it reduces the risk of recurrence, prophylactic drug 
treatment does not attenuate the trend toward increasing severity of subsequent 
depressive episodes (Maj et al., 1992). 
In 2008, Kirsch and colleagues obtained data on all clinical trials with full 
datasets that have submitted to the US Food and Drug Administration for licensing of 
new-generation antidepressants. They found virtually no difference between drug and 
placebo in patients with moderate levels of depression, rising to small difference in 
patients with very severe depression, and reaching clinical significance only in 
patients at the upper end of the very severely depressed category. The researchers 




severely depressed patients unless alternative treatments have been ineffective. 
Similarly, Turner and colleagues (2008) examined all published and unpublished data 
on antidepressant medications between 1987 and 2004. They found that 
approximately half of the studies produced significant drug-placebo differences, 
although the published literature – by not reporting on 92% of the nonsignificant 
trials – misleadingly implied that 94% of the trials were significant. 
Despite the aforementioned limitations of antidepressant medication use as a 
prevention strategy, it still constitutes – by far – the most widely used approach in 
contemporary clinical practice. Antidepressants were the most prescribed class of 
drugs in the United States in 2006 (Spielmans, Thiegles, Dent, & Greenberg, 2008), 
and have garnered widespread acceptance among clinicians, the public, and the media 
alike (Greenberg & Goldman, 2009). Reasons for the popularity of medications may 
include the simplicity of taking a pill to alter mood, rather than the more intensive and 
difficult process of therapy, the low time commitment and ease of use perceived by 
both patients and practitioners, and financial support provided by insurance and 
pharmaceutical industries (Greenberg & Fisher, 1997). Other preventive strategies, 
such as ongoing (maintenance) psychotherapy, are rarely employed after the initial 
treatment for depression (Jarrett et al., 2001). 
Psychotherapy 
Although the number of published studies examining the effects of preventive 
psychotherapy interventions for mental disorders is not large, a considerable 




Barber, 2001 and Cuijpers, Van Straten, & Smit, 2005, for reviews). A related 
literature has examined a felicitous “byproduct” of some forms of acute 
psychotherapy for depression – a reduced risk of subsequent relapse. In other words, 
the beneficial effects of psychotherapy often endure long after treatment 
discontinuation (Jarrett et al., 2001; Seligman et al., 1999), and this prophylactic 
advantage seems to be larger than that observed with pharmacotherapy. For example, 
in a review of eight follow-up studies comparing cognitive therapy (CT) with 
antidepressants, Gloaguen et al. (1998) observed an average relapse rate twice as high 
among patients treated acutely with antidepressants (60%) compared with those 
treated with CT (29.5%). Although therapy is often more costly than 
pharmacotherapy, it may be regarded as an attractive alternative if it provides 
protection against recurrence (Hollon, DeRubeis, & Seligman, 1992). 
Prophylactic effects of acute CT.  The existing literature suggests that the 
enduring prophylactic effects of acute treatment are stronger for cognitive therapy 
(CT) than for medication. For example, Hollon et al. (2005) conducted a randomized 
controlled trial examining relapse prevention following CT versus medications. At a 
one-year follow-up, patients withdrawn from CT were significantly less likely to 
relapse (31%) than patients withdrawn from medications (76%), and no more likely 
to relapse than patients who continued taking continuation medication (47%). 
Almeida and Neto (2003) conducted a review on the risk of relapse and recurrence 
following similar randomized controlled trials of CT for acute depression. In 12 of the 




comparison with a control condition (typically antidepressant medication). The 
reviewers concluded that CT is efficacious in preventing relapse largely by virtue of 
its effect in relieving residual subclinical depressive symptoms. 
CT-based prevention programs.  Essau (2004) noted that most programs 
designed specifically for the prevention of depression are based upon the principles 
and techniques of CT, due in part to the aforementioned enduring benefit of acute CT. 
Preventive CT interventions are typically provided as a continuation treatment 
following acute therapy, either as a stand-alone intervention or as an adjuvant to 
medication or other treatments. Evidence to date indicates that the preventive effect 
may be stronger for continuation CT than for continuation medication (Dobson & 
Ottenbreit, 2004). For example, Jarrett and colleagues (1998) compared two groups of 
patients who both received acute CT. The study prevention group received an 
additional eight months of continuation CT. Relapse rates were significantly lower for 
the treatment group than for the no-intervention control group at follow-up (20% 
versus 40% at 6 months; 36% versus 70% at 24 months; Jarrett et al., 2001). In a 
series of impressive two- and six-year follow-up studies, Fava and colleagues (Fava 
et al., 2004; Fava, Rafanelli, Grandi, Conti, & Belluardo, 1998b) compared two 
groups of remitted patients, one of which received CT maintenance treatment while 
the other received only routine clinical management. Relapse rates were significantly 
lower for the CT treatment group than for the control group at both follow-ups (25% 




Bockting et al. (2005) conducted a randomized controlled trial with a 
preventive group CT intervention among high-risk patients with recurrent depression. 
All patients received treatment as usual, including continuation of medications, but 
the treatment group also received eight weekly two-hour sessions of CT. Among 
patients with five or more previous episodes, CT reduced the relapse rate from 72% 
to 46% at a two-year follow-up. Similarly, Paykel et al. (1999) compared two groups 
of remitted patients that continued to experience subclinical symptoms. Both groups 
received continuation medication, but one group received an additional CT preventive 
intervention. At a 17-month follow-up, relapse rates were significantly lower in the 
CT treatment group (29% versus 47% in the medication-only control group). In the 
same sample, the effects of CT on reduction of recurrence persisted for some time, 
although with a gradual weakening. The prophylactic benefit of CT was fully lost 
within four years (Paykel et al., 2005). 
Not all published findings, however, support the efficacy of CT as a 
prevention strategy. For example, Sheffield and colleagues (2006) evaluated multiple 
types of CT programs for prevention of both first-onset and relapse of depression 
among 2,479 adolescents in 34 different schools. They observed that none of the CT 
programs yielded outcomes that differed significantly from their respective no-
intervention conditions. Cole and Dendukuri (2004) likewise conducted a review of 
brief CT interventions to prevent depression in older adults. Only two of 10 reviewed 
studies yielded statistically significant differences in depression outcome scores 




patients experiencing subclinical symptoms following an acute treatment with 
fluoxetine (a selective serotonin reuptake inhibitor). Post-intervention, both groups 
received continuation fluoxetine, but one group also received CT. At a 28-week 
follow-up, the addition of CT did not lead to lower rates of relapse or treatment 
discontinuation. Also problematic is the fact that maintenance sessions of CT have 
not been found to be more effective than either nonspecific “supportive therapy” 
sessions or no treatment at all among the subset of patients who have fully recovered 
by the end of acute treatment (Baker & Wilson, 1985; Kavanagh & Wilson, 1987). In 
conclusion, CT may be considered the most efficacious preventive therapy for 
depression to date and reduces the risk of relapse by about half. On the other hand, a 
considerable percentage of depressed individuals relapse despite CT-based 
prevention, and some studies directly refute the effectiveness of CT. 
Other therapeutic prevention programs.  A few other forms of psychotherapy 
have also been developed for the prevention of depression. For example, Teasdale 
and colleagues (Ma & Teasdale, 2004; Segal, Williams, & Teasdale, 2002; Teasdale 
et al., 2000) have created “mindfulness based cognitive therapy” (MBCT), a program 
that augments CT techniques with traditional mindfulness meditation. Patients are 
taught to disengage from depressive thoughts and to experience thoughts and feelings 
without responding or catastrophizing (see Waller, Carlson, Englar-Carlson, 2006 for 
a session-by-session review). These techniques were designed for the specific 
purpose of preventing recurrent depression (Teasdale, Segal, & Williams, 1995). 




trials of MBCT (Ma & Teasdale, 2004; Teasdale et al., 2000) have found that patients 
with three or more previous depressive episodes experience a significantly reduced 
relapse rate following MBCT in comparison with “treatment as usual.” However, 
MBCT patients with only two previous episodes actually showed a nonsignificant 
increased rate of relapse compared with treatment as usual. Thus, the prophylactic 
benefit of MBCT may only apply to patients with more extensive histories of 
repeated depression (Segal et al., 2002).  
Fava and colleagues (Fava, Rafanelli, Cazzaro, Conti, & Grandi, 1998a) have 
created “Well-Being Therapy,” a program designed to help remitted patients self-
monitor their symptoms and target six therapeutic goals: environmental mastery, 
personal growth, purpose in life, autonomy, self-acceptance, and developing positive 
relationships. Preliminary research indicates that this therapy may be as effective as 
preventive CT in preventing relapse (Fava et al., 1998a; Rafanelli, Park, & Giovanni, 
1999). 
Interpersonal psychotherapy (IPT) may also confer protective benefit, 
inasmuch as it extends the well interval for patients with recurrent depression (Frank 
& Spanier, 1995). Young and colleagues (Young, Mufson, & Davies, 2006) tested the 
prophylactic efficacy of a group IPT program for subclinically depressed adolescents. 
At three- and six-month follow-ups, adolescents who received IPT had significantly 
fewer symptoms, better overall functioning, and fewer depression diagnoses than 
adolescents in usual care (school counseling). A recent review of IPT as an acute 




than after medication or placebo (de Mello, de Jesus Mari, Bacaltchuk, Verdeli, & 
Neugebauer, 2005). 
On the other hand, several findings have failed to support the preventive 
benefit of IPT. Reynolds and colleagues (1999) compared IPT to nortriptyline (a 
second generation tricyclic antidepressant) as maintenance treatments for elderly 
patients with recurrent depression. Recurrence rates over three years were as follows: 
nortriptyline and IPT, 20%; nortriptyline and medication visits, 43%; IPT and 
placebo, 64%; placebo and medication visits, 90%. Although combined treatment 
with nortriptyline and IPT was most effective, IPT with placebo was not significantly 
more effective than nortriptyline with medication visits. Similarly, at an 18-month 
follow-up, Shea et al. (1992) found no significant differences in recovery between 
four treatments: IPT, imipramine, CT, or placebo. The rate of recovery was low, 
ranging from 19% to 30%. Frank et al. (1990) used maintenance IPT to significantly 
extend the duration of time patients stayed well before becoming depressed again. 
However, even though the time to relapse was lengthened with IPT, relapse still 
eventually occurred for most study patients, and IPT again conferred no benefit above 
and beyond medication alone. Short-term psychotherapy, specifically IPT or CT, does 
not have enduring effects for many individuals, particularly in the long term (Frank & 
Spanier, 1995). 
Prevention for Youth 
Several studies have also evaluated psychotherapeutic depression prevention 




onset, with mixed results. Clarke et al. (2001) successfully used a relatively brief (15-
session) cognitive therapy program with a group of adolescents at risk for depression 
due to subclinical symptoms or genetic predisposition. At six- and twelve-month 
follow-ups, adolescents in the treatment group had fewer depressive symptoms and a 
lower proportion of diagnosable cases (14.7%, versus 25.7% in the control condition). 
Jaycox et al. (Jaycox, Reivich, Gillham, & Seligman, 1994) tested a program 
designed to modify cognition, promote social problem solving, and induce efficient 
cognitive processing among mildly depressed children ages 10-13. Results indicated 
an acute decrease in symptoms and a reduction in acting-out behaviors, in addition to 
a sustained decrease in depressive symptoms at six-month and two-year follow-ups. 
However, because the study had no control group, it is not possible to definitively 
attribute the observed improvement to the treatment. Another study using a very 
similar program yielded no significant effect on depressive symptoms (Roberts, Kane, 
Thomson, Bishop, & Hart, 2003). Shochet and colleagues (2001) tested two 
prevention programs for all ninth-year students in a secondary school in Australia. 
One program focused on the adolescents, using coping, cognitive, and interpersonal 
skills. The other program focused on parents, with a concentration on similar skills. 
Both prevention groups showed fewer depressive symptoms than a control group at a 
10-month follow-up, though there were no significant differences between the two 
groups. 
Seligman and colleagues (Seligman, Schulman, & DeRubeis, 1999) have 




students did not have MDD, but displayed a pessimistic explanatory style – an 
established risk factor for the development of MDD. The preventive program focused 
on the enhancement of cognitive coping skills, and it was implemented weekly for 
two hours over a span of eight weeks, with added occasional individual sessions. A 
three-year follow-up revealed a trend toward fewer depressive symptoms, fewer 
dysfunctional thoughts, less hopelessness, a more positive explanatory style, and 
fewer cases of generalized anxiety disorder among treated individuals. However, 
there was no significant reduction in the likelihood of experiencing a diagnosable 
depressive episode. 
Lifestyle Factors With Preventive Benefit 
 In addition to pharmacological and psychotherapeutic interventions, several 
lifestyle variables have been evaluated with respect to their potential prophylactic 
benefit vis-à-vis depression onset. Following is a brief review of relevant factors: 
Dietary Omega-3 Fatty Acids 
Omega-3 and omega-6 fatty acids together constitute over 20% of brain tissue 
and are necessary for neural structure and efficient function (Uauy & Dangour, 2006). 
These essential fats cannot be made by the body, but must be obtained from diet. 
Over the vast majority of time during which the human genome evolved, humans 
consumed a ratio of approximately 1:1 omega-3 to omega-6 fatty acids, and this 
remains the optimal ratio for humans today (Simopoulos, 2006). However, there has 




current ratio of omega-3 to omega-6 in Western diets is approximately 1:15 (Eaton & 
Eaton, 2000; Simopoulous, 2003). 
Evidence for an important linkage between major chronic diseases of 
industrialized society and the typical Western diet is steadily rising (Eaton & Konner, 
1985). For instance, the incidence of major depression is lower in those countries in 
which natural sources of omega-3 (such as fish) form a key element of the normal 
diet than in other countries where omega-3 consumption is relatively low (Hibbeln, 
1999). Compared with healthy individuals (Hasegawa, 1985), depressed individuals 
around the world have lower plasma levels of omega-3 fatty acids (Adams, Lawson, 
Sanigorski, & Sinclair, 1996; Edwards, Peet, Shay, & Horrobin, 1998; Tanskanen et 
al., 2001; Tiemeier, van Tuijl, Hofman, Kiliaan, & Breteler, 2003). Several recent 
studies have also supported the benefit of omega-3 supplementation in treating acute 
depression (Nemets, Nemets, Apter, Bracha, & Belmaker, 2006; Nemets, Stahl, & 
Belmaker, 2002; Peet & Horrobin, 2002; Silvers, Woolley, Hamilton, Watts, Watson, 
2005; Su, Huang, Chiu, & Shen, 2003) and postpartum depression (Freeman et al, 
2006). A deficiency of omega-3s in depressed individuals may be exacerbated by the 
appetite loss and decreased food intake characteristic of many cases of depression 
(Adams et al., 1996). The most effective daily dosage for acute treatment of 
depression seems to be 1 g of the omega-3 fat known as eicosapentaenoic acid (EPA) 
(Peet & Horrobin, 2002; Silvers et al., 2005). 
Although there are no known published studies designed specifically to 




EPA supplementation helps prevent relapse in patients who suffer from recurrent 
depression (e.g., Peet & Horrobin, 2002; Nemets et al., 2002). Sublette and 
colleagues (Sublette, Hibbeln, Galfalvy, Oquendo, & Mann, 2006) have also found 
that low levels of omega-3 fatty acids and high omega-6:omega-3 ratios are 
associated with a risk for suicidal behaviors, one of the hallmark features of MDD. 
In addition, at least two studies provide indirect evidence to suggest that a 
preventive omega-3 intervention would be effective. Huang, Yang, Chiu, Pariante, 
and Su (2006) used an animal model demonstrating that a diet enriched with omega-3 
fatty acids provides a prophylactic benefit. In this study, rats were assigned either to a 
normal diet or to a diet supplemented with omega-3 fats. Both groups were then 
subjected to a forced swim test, which induces a state of despair similar to depression, 
and which is often used to evaluate the human antidepressant potential of trial 
medications. The investigators found that rats treated with an omega-3 diet exhibited 
significantly less despair; that is, the omega-3-fed rats spent a significantly higher 
amount of time swimming and climbing (active behavior) and significantly less time 
remaining stationary (passive behavior). 
 Stoll et al. (1999) have also found that EPA is useful as a preventive measure 
for bipolar disorder – with particular efficacy in preventing the onset of depressive 
symptoms. Stoll and colleagues also noted that participants who received EPA were 
significantly less likely to drop out of the study. The three who received EPA and did 
drop out attributed their drop-outs to an increase in suffering due to mania, 




and dropped out, nine out of ten attributed their drop-outs to an increase in depressive 
symptoms.  
Exercise 
 Residents of modern industrialized nations typically exert far less physical 
energy in the course of daily life than people have over the vast majority of human 
history (Molnar, 2005). Almost 60% of American adults do not engage in any regular 
physical exercise at all (Centers for Disease Control and Prevention, 2003). This is a 
cause for concern because exercise confers protective benefit from a variety of 
illnesses, both physical and psychological. In fact, since the mid-1980s it has been 
suspected that aerobic exercise provides antidepressant effects (McNeil, LeBlanc, & 
Joyner, 1991; Ross & Hayes, 1988; Simons, McGowan, Epstein, Kupfer, & 
Robertson, 1985; Stephens, 1988). 
In more recent years, strong evidence has emerged to support the 
antidepressant benefit of regular exercise (Beck, Steer, & Garbin, 1988; Babyak et al., 
2000; Dunn, Trivedi, Kampert, Clark, & Chambliss, 2005; Mather et al., 2002; see 
Brosse, Sheets, Lett, & Blumenthal, 2002, for a review). In fact, exercise appears to 
be equally effective in reducing depressive symptoms as psychotherapy or 
antidepressant medications (Fremont & Craighead, 1987; Greist et al., 1979; 
Blumenthal et al., 1999; Blumenthal et al., 2007). Purath and colleagues (Purath, 
Miller, McCabe, & Wilbur, 2004) implemented a single-session intervention to 




intervention group had significantly improved their physical activity, indicating that 
even very brief programs may help patients increase their level of exercise. 
There is also correlational evidence suggesting that physical activity may be 
useful in the prevention of depression (Ross & Hayes, 1988). Longitudinal studies 
have clearly shown that regular exercise habits do predict subsequent freedom from 
depression (Salmon, 2001; Stephens, 1988). For example, Paffenbarger, Lee, and 
Leung (1994) found that physical activity was negatively correlated with depression 
over the course of 25 years. In contrast, Camacho and colleagues (Camacho, Robert, 
Lazarus, Kaplan, & Cohen, 1991) found that lack of physical activity was associated 
with a greater likelihood of subsequent depression over 18 years, even after 
controlling for several relevant demographic and clinical variables. Of course, it may 
simply be that non-depressed individuals are more likely to exercise than depressed 
individuals. However, studies have also controlled for preexisting depression and still 
found that regular exercise helps ward off future depression (Farmer et al., 1988; 
Mobily, Rubenstein, Lemke, O’Hara, & Wallace, 1996; Stewart et al., 1994). 
Exercise also appears to be useful in the prevention of depression relapse. 
Blumenthal et al. (1999) compared aerobic exercise, antidepressants, and combined 
exercise and medication. Although no significant difference in improvement was 
found between any of the three groups after four months of treatment, after six 
months it was found that patients in the exercise-only group were at a significantly 
lower risk of relapse (Babyak et al., 2000). Patients who continued exercising on their 




exercise may help with relapse prevention. Two years after an acute exercise 
intervention, participants were still less depressed than those in the no-exercise 
control group. Furthermore, 94% of study participants continued exercising on their 
own, without supervision. This is impressive given that feasibility, compliance, and 
long-term adoption are issues of paramount importance for any effective treatment 
(Singh et al., 2001). Salmon (2001) suggested that exercise may be a particularly 
effective treatment for patients for whom more conventional interventions are less 
acceptable, perhaps due to financial reasons, feasibility, or simple unwillingness. 
Researchers have also considered what type of exercise is most efficacious in 
the amelioration of depression. It appears that relatively intensive, active exercise, 
such as running or biking, is more effective than exercise that requires less intensity, 
such as stretching or flexibility training (Dunn et al., 2005). Although some studies 
comparing aerobic and anaerobic exercise have not found a significant difference in 
efficacy (e.g., Doyne et al., 1987; see Lawlor & Hopker, 2001, for a review), the 
majority of published controlled studies have utilized aerobic exercise. With respect 
to antidepressant exercise “dosage,” it seems that the determining factor is total 
energy expenditure. Dunn et al. (2005) found that there was no difference in benefit 
between participants who exercised three days a week and those who exercised five 
days a week, as long as the weekly output of energy was in the active, aerobic range 
(17.5 kcal/kg/week). No matter what kind of exercise individuals choose, the fact that 




clinical benefit, patients should feel in control of their exercise regimen (Salmon, 
2001) and personalize it to meet their own preferences and needs. 
Sunlight Exposure 
Residents of industrialized nations typically spend very little time outdoors. 
Remarkably, direct outdoor sunlight is up to 100 times brighter than the intensity of 
incandescent or fluorescent indoor lighting (Reynolds et al., 2001). This has 
important implications, inasmuch as adequate light exposure is necessary for 
regulation of circadian rhythms, sleep regulation, retino-hypothalamic pathways, 
cortisol, and melatonin attenuation (Küller, 2002), all of which impact mood 
regulation and psychological functioning (Neuhaus & Rosenthal, 1997). 
Unfortunately, in a relevant study of people living in San Diego, a relatively weather-
friendly and sunny area, the average resident spent only 58 minutes in daylight each 
day (Espiritu et al., 1994).  
Depressed individuals who are particularly sensitive to seasons with reduced 
light may be diagnosed with seasonal affective disorder (SAD). SAD occurs in a 
nontrivial subset of the population like clockwork each year, triggered by the short, 
cold, and cloudy days of winter and subsequent time spent indoors. Indeed, up to 20% 
of North Americans suffer from winter-onset depressive symptoms (Miller, 2005). 
Bright light therapy is the least invasive, most natural, and most researched treatment 
for seasonal affective disorder (Lam et al., 2006; Miller, 2005). Regular time outdoors 
during daylight hours is an effective alternative to artificial light therapy in the 




Bright light exposure appears to be a good adjunct treatment for nonseasonal 
depression, as well (Martiny, Lunde, Unden, Dam, & Bech, 2005). In fact, it seems 
that light exposure therapy alone can bring up to 35% symptom relief of nonseasonal 
MDD (for reviews, see Tuunainen, Kripke, & Endo, 2004; Kripke, 1998). Responses 
to light therapy are as rapid in nonseasonal patients as in patients with seasonal 
depression, and light therapy is comparable to antidepressant medications in its 
effectiveness (Kripke, 1998). Light therapy tends to work more quickly than 
medications, with some patients experiencing benefit within the first week of 
treatment, as opposed to waiting several weeks or longer for the medication to take 
effect (Kripke, 1998; Martiny et al., 2005). 
Therefore, light therapy may be an especially effective tool in preventing the 
onset of a depressive episode, particularly for individuals who are already 
experiencing subclinical symptoms, i.e., those who could easily lapse into a more 
serious episode. Artificial bright light therapy can also be used prophylactically when 
patients are approaching the fall and winter seasons. Espiritu and colleagues (1994) 
found that individuals who spent more than 30 minutes a day in bright light reported 
little depressive symptomatology, whereas some of those experiencing less 
illumination reported substantial symptoms. Because chronic low illumination may 
cause depressive symptoms in susceptible individuals, it is logical to infer that 







Americans and other Westerners typically live in urban areas surrounded by 
thousands or millions of other unrelated humans with whom they often feel little if 
any meaningful connection (Buss, 2000). Social isolation and a notable lack of 
intimate social bonding have increasingly become a normal part of life (Putman, 
2000). Modern methods of communication such as e-mail and telephone have made it 
possible to completely avoid regular face-to-face social contact if one so desires. 
Research indicates that the number of close “discussion partners” in the typical 
American’s interpersonal environment has decreased by about one person since 1985 
(from a mean of 2.94 to a mean of 2.08), and that the modal number of discussion 
partners has gone from three to zero (McPherson, Smith-Lovin, & Brashears, 2006). 
It has been known for decades that social support is an important stress-
buffering factor, one that promotes physical (e.g., reduced blood pressure; Gump, 
Polk, Kamarck, & Shiffman, 2001; Holt-Lunstad, Uchino, Smith, Olson-Cerny, & 
Nealey-Moore, 2003) and emotional health (Cohen, McGowan, Fooskas, & Rose, 
1984; Leavy, 1983; Lin, Dean, & Ensel, 1986; Seeman, 1996; Wilcox, 1981). Lack of 
social support is considered one of the primary vulnerability factors for the onset of 
depression (Murray, 1995). Withdrawal from social activities is one of the central 
symptoms of depression (American Psychiatric Association, 2000), reflecting 
depressed individuals’ social deficits. To that end, interpersonal psychotherapy (IPT) 
was designed specifically to target depressed patients’ immediate social context (see 




prevention of MDD (e.g., Reynolds et al., 1999; Santor & Kusumakar, 2001; for a 
review, see de Mello et al., 2005) reflects the importance of social connectedness in 
mental health. Brown and Lewinsohn (1984) examined the efficacy of an acute 12-
week psychoeducational intervention for major depression targeting, among other 
variables, increasing pleasant activities and positive social interactions. At a six-
month follow-up, only 25% of participants met criteria for depression. It seems that 
the relationship between social support and mental health is bi-directional (Johnson, 
1991). In other words, depressed individuals are less likely to attract or maintain 
relationships. Subsequent isolation causes these individuals to become more 
depressed. Thus, the relationship between these two variables is self-maintaining and 
intensifies over time. 
Social connection may also have preventive value. It is associated with 
continuing recovery from depression (Reynolds et al., 1999) and is one of the factors 
most strongly related to complete remission from depression after acute treatment 
(Ezquiaga, Garcia, Pallares, & Bravo, 1999). Oxman and colleagues (Oxman, 
Berkman, Kasl, Freeman, & Barrett, 1992) examined the longitudinal effects of 
emotional support in an elderly population. They found that the greater the adequacy 
of social support, the lower was the level of depression three years later. This 
association was found even when other determinants of depression were controlled 
for, such as disability and socioeconomic variables. It seems that inadequate social 
support directly contributes to an increase in depressive symptoms. Likewise, a 




(Dean, Kolody, & Wood, 1990; Krause, 1987; Seeman et al., 1996; see Broadhead et 
al., 1983 for a review of older literature) and also reduces the risk of depression 
recurrence in the post-recovery period (de Mello et al., 2005; George, 1989). 
Anti-Ruminative Activity 
Rumination, or the tendency to engage in repetitive negative thinking, is a 
central cognitive process in depression (Ingram, 1984; Lam, Smith, Checkley, 
Rijsdijk, & Sham, 2003; Nolen-Hoeksema, 1991). There are at least three 
mechanisms by which rumination amplifies depressed mood and by which distraction 
can relieve it (Morrow & Nolen-Hoeksema, 1990). First, depressed mood increases 
the likelihood of recalling negative information (Clark & Teasdale, 1982). Individuals 
who distract themselves from their mood will be less likely to reach negative 
conclusions (Morrow & Nolen-Hoeksema, 1990). Second, rumination maintains and 
intensifies depressed mood by evoking maladaptive cognitions more often (Ingram, 
1984; Zullow, Oettingen, Peterson, & Seligman, 1988). Third, rumination interferes 
with attention, concentration, and behavioral initiation (Lewinsohn, Hoberman, Teri, 
& Hautzinger, 1985), leading to fewer opportunities for positive reinforcement and 
success. 
American life today offers ample opportunity for rumination (Ilardi, 
Karwoski, Lehman, Stites, & Steidtmann, 2009). Rumination is most likely to happen 
when people are not involved in another mentally stimulating activity (Morrow & 




offices, watching television, driving – often alone, allowing abundant occasions to 
ruminate (Cropley & Purvis, 2003). 
Two therapies have been shown to be effective in reducing rumination: 
metacognitive therapy (Wells & Papageorgiou, 2004) and behavioral activation (BA; 
Martell, Addis, & Jacobson, 2001). Metacognitive therapy focuses on teaching 
patients about rumination, helping them become aware of its real-time occurrence, 
and implementing anti-rumination strategies. In turn, behavioral activation typically 
focuses on increasing rewarding physical activities. Increased pleasant activities and 
increase in general activity level are associated with relief from depression (Rehm, 
1982). Both strategies may be valuable approaches to decreasing rumination, 
especially the notion of engaging in activities that suppress rumination (Dimidjian et 
al., 2006; Ilardi et al., 2009; Karwoski, 2006). 
Dimidjian and colleagues (2006) conducted a randomized trial of behavioral 
activation, cognitive therapy (CT), and antidepressant medication. In contrast to CT, 
which directly targets thought content, behavioral activation and metacognitive 
strategies were used to identify ruminative thinking and to turn their attention away 
from rumination by engaging in active behaviors as alternatives. Specific activation 
strategies included self-monitoring and structuring and scheduling daily activities. 
Remarkably, behavioral activation proved superior to antidepressant medication 
(paroxetine) among severely depressed study patients and significantly outperformed 
traditional CT. Other research has supported the hypothesis that behavioral activation 




relapse over a two-year period (Gortner, Gollan, Dobson, & Jacobson, 1998; 
Jacobson et al., 1996). Such anti-ruminative, behavioral activation strategies make 
intuitive sense: ruminative responses tend to increase the length and severity of 
depressive thoughts, whereas distracting responses can attenuate the experience of 
depressive symptoms (Nolen-Hoeksema, 1987). 
Anti-rumination strategies may be useful in preventing depressive episodes as 
well. People who ruminate are at a higher risk for longer-lasting and more severe 
depression (Lam et al., 2003; Nolen-Hoeksema & Morrow, 1993). Rumination can 
serve to maintain a depressed mood, and a proneness to ruminate has been identified 
as a marker of subsequent depression vulnerability in individuals who are not yet 
depressed (Just & Alloy, 1997).  
Sleep 
 Sleep abnormalities are commonly found in individuals suffering from MDD, 
as evidenced by cardinal diagnostic symptoms that include insomnia, restless sleep, 
or hypersomnia (APA, 2000). In addition to constituting a key symptom of 
depression, sleep disturbance also contributes to the onset of a depressive episode. 
While it has historically been assumed that depression causes sleep problems, the 
converse also appears to be true: disturbed sleep and the dyschronism of circadian 
rhythms are risk factors for the development or exacerbation of depression (Katz, 
Knobler, Laibel, Strauss, & Durst, 2002; Kuo, Manber, & Loewy, 2001; Morawetz, 
2003). Insomnia and hypersomnia (Breslau, Roth, Rosenthal, & Andreski, 1996; 




and general sleep disturbance (Cole & Dendukuri, 2003) all put people at a much 
higher risk for developing major depression. In a review of eight studies, Reimann 
and Voderholzer (2003) found that insomnia at baseline significantly predicted an 
increased depression risk at a follow-up one to three years later. They suggested that 
insomniac symptoms alone seem to be of predictive value for the development of 
depression. 
 Interventions designed to enhance both the quality and quantity of sleep have 
been found effective in treating depression (Morawetz, 2003; Kuo, Manber, & 
Loewy, 2001). Likewise, it is clear that maintaining healthy sleep helps prevent the 
onset of depression. Sleep disturbance is the most common symptom to linger after 
successful treatment for acute depression, reported by 44% of patients (Nierenberg, 
Alpert, Pave, Worthington, Rosenbaum, & Fava, 1999). Breslau and colleagues 
(1996) conducted a longitudinal study examining the predictive value of sleep 
disturbance. They found that the mental disorder most strongly associated with sleep 
disturbance was MDD, even when the diagnosis of MDD was made on the basis of 
symptoms other than sleep disturbance. In particular, insomnia was a better predictor 
of subsequent depression than any other single depressive symptom. The authors 
suggested multiple explanations for the insomnia–MDD association. First, insomnia 
may be an early symptom of MDD, with other symptoms appearing later on. Second, 
insomnia due to exogenous factors may play a causal role in actually precipitating the 
onset of MDD in predisposed individuals. Either way, the presence of sleep 




experienced depression. Even mild insomnia has a significant association with 
depression (Hohagen, Rink, Käppler, & Schramm, 1993). Taking steps to prevent 
sleep disturbance or to deal with disturbance if it arises should help prevent the onset 
of a depressive episode. 
 These six lifestyle factors – omega-3 fatty acids, exercise, sunlight exposure, 
social support, anti-ruminative activity, and sleep – may all have a common 
denominator. Each is an element that was once a common, even unavoidable, aspect 
of daily human life. In the modern Western world, however, these elements are much 
more limited and elusive, requiring special effort to be regularly integrated into life. 
What is known about the relative lack of these healthy lifestyle factors, and how does 
this deficit relate to clinical depression? 
An Evolutionary Model of Depression 
 It has been estimated that the risk of developing major depression has 
increased tenfold in the U.S. since World War II (Seligman, 1990). Moreover, 
individuals who live in developing countries are at a lesser risk of developing MDD 
than those who live in industrialized nations, such as the United States (Weissman et 
al., 1996). Even within less modernized countries, depression rates are higher among 
city dwellers with more modern lifestyles than among rural people (Colla et al., 
2006). It seems that the more modernized a country is, the higher the risk is of its 
residents developing depression (Ilardi et al., 2009). Indeed, the risk of depression 
varies according to the extent of modernization. Countries with lifestyles most 




prevalence rates of depression (Schumaker, 1996). Within the United States, there is 
an example of a traditional community characterized by a markedly reduced risk of 
depression: the Old Order Amish of Pennsylvania, known for their separateness from 
the modern world. Lifetime rates of MDD in the Amish culture are far lower, as much 
as one-tenth of that of other Americans – which is about the rate for all Americans 
two generations ago, when life was somewhat less “modernized” (Egeland & 
Hostetter, 1983). A traditional lifestyle seems to offer protection against the negative 
effects of modernization (Colla et al., 2006). 
Research shows that today’s hunter-gatherer societies experience a 
particularly low risk of depression. For example, the Toraja people of Indonesia 
(Hollan, 1992; Schumaker, 1996) and Trobriand Islanders of Melanesia (Maier, 1996) 
were found to be extremely resilient to the onset of depression. Schieffelin (1985) 
spent years studying the Kaluli people, a traditional hunter-gatherer community in 
Papua New Guinea. Among the thousands of Kaluli assessed for MDD, Schieffelin 
was able to find only one individual who was symptomatic, despite his observation 
that the culture encouraged its members to openly and even dramatically display a 
range of emotions. In contrast, Americans suffer from a suspiciously high lifetime 
prevalence of MDD (16.2%; Kessler et al., 2003). It seems that modern culture is 
lacking in preventive buffers to protect its members from depression. It is possible, 
then, that major depression is less an issue of individual pathology, but more of a 




It is thus hypothesized that the recent increase in the prevalence of MDD, 
particularly in industrialized Western cultures, is at least in part due to modernization 
itself. There is evidence that there is a fundamental mismatch (Ilardi et al., 2009; 
Karwoski, 2006) between the modern environment and the environment of 
evolutionary adaptiveness (EEA; Bowlby, 1969), in which humans have spent the 
vast majority of their existence. The further a society gets from an EEA-like setting, 
the more at risk they seem to be for depression. Likewise, the closer a society is to the 
EEA way of life, the more immune their members are to developing multiple diseases 
(Cosmides & Tooby, 1999), including depression (Buss, 2000; Prince, 1967). This 
hypothesis also explains the increasing prevalence of depression and younger age of 
onset among younger cohorts in America (Kessler & Walters, 1998; Kessler et al., 
2003). As younger individuals embrace lifestyles that are increasingly modernized, 
the risk of depression increases. 
At first glance, it seems that the modern, post-industrial lifestyle has delivered 
innumerable conveniences, medical advances, technological innovations, and 
comforts. Most people no longer find it necessary to hunt for food, flee from 
predators, lift heavy objects, or rely on physical prowess for survival. Physicians are 
able to cure ills that would have sentenced our ancestors to a quick and painful death; 
women no longer run a high risk of dying during childbirth; very few individuals 
suffer from hunger, endure prolonged exposure to inclement weather, or face the 
direct threat of predators or parasites. The average life expectancy of Americans is 




Shostak, 1988). Many people might agree that, overall, life is easier and safer than it 
once was. 
The question arises, then: what is so psychologically toxic about modern life? 
Why are Americans at such great risk for depression? Evolutionary researchers 
suggest that modern circumstances may also be causing a variety of problems that 
humans must face. For example, our hunter-gatherer ancestors regularly engaged in 
vigorous physical activity for a variety of activities, including both work and play 
(Molnar, 2005). In contrast, a majority of modern American adults do not engage in 
any physical exercise at all (Centers for Disease Control and Prevention, 2003). In 
ancestral times, people lived in small groups with other people, many of whom were 
their close genetic relatives. These groups were characterized by a high level of 
support and interdependence, and social isolation was virtually absent (Gat, 1999). 
Not only did group activities enhance survival (Molnar, 2005), they offered the 
chance to socialize a great deal (Deacon, 1999). In comparison, complete social 
isolation is now a normal part of American life (Putman, 2000). These and other 
features of ancestral hunter-gatherer life helped combat rumination (Ilardi et al., 
2009; Karwoski, 2006), thought to be a central problem in modern-day depression 
(Ingram, 1984). 
In the Western world, the past century has accelerated the differentiation of 
humans from other mammals (Eaton et al., 1988). While human bodies and mind 
remain unchanged, shaped by selection pressures in the EEA, the environment has 




over the past 10,000 years, especially since the Industrial Revolution, but  human 
genes have hardly changed at all (Eaton et al., 1988). In other words, humans are well 
adapted to the world of their ancestors – not to the one they live in today. 
Environmental changes might readily influence the human genome given sufficient 
time, but such rapid innovation has overreached the capacity of evolution to keep 
pace (Eaton & Eaton, 2000). 
Many mental disorders may be the products of mechanisms functioning 
normally but in currently maladaptive circumstances (Siegert & Ward, 2002). 
Depression, especially in its severe form (MDD), is perhaps not “meant to happen,” 
but is a result of modern times. This is not to say that particular individuals are not at 
higher risk for depression. Certainly, clear genetic risk has been identified (e.g., 
Kendler, Gatz, Gardner, & Pedersen, 2007), along with individual psychological 
vulnerability factors (e.g., negative automatic thoughts and tendency toward self-
blame; Ingram, Trenary, Odom, Berry, & Nelson, 2007). However, phenotypic 
expression of genetic vulnerability to clinical depression is highly dependent on the 
environment (Kendler, 1998; Silberg, Rutter, Neale, Eaves, 2001; Uher, 2008), and 
the alarmingly high rate of depression in the American population in contrast to less 
modernized societies suggests that the current way of life may put all individuals, 
vulnerable or not, at higher risk. To this end, Ilardi and colleagues (2009) argue that 
the recent epidemic of depression is a result of the gradual disappearance of lifestyle 
elements that are natural antidepressants. In order to gain relative freedom from 




backward in time and reintroduce essential lifestyle elements from the Paleolithic 
world (Eaton et al., 1988). This theoretical backing led to a new treatment for 
depression based on re-incorporating lost antidepressant elements. 
Therapeutic Lifestyle Change for Depression 
Ilardi and colleagues (2009) have developed a novel treatment protocol based 
on an evolutionary model of depression. The treatment rests on the notion that 
depression is caused by a severe lack of natural lifestyle elements that provide a 
strong antidepressant benefit. These lifestyle elements include: physical exercise, 
dietary omega-3 fatty acids, sunlight exposure, sleep, social support, and anti-
ruminative activity. Accordingly, a 12-session group therapy program, Treatment 
Lifestyle Change for Depression (TLC), was developed to help patients implement 
these various lifestyle elements that are often lacking in our modern world. 
Preliminary data suggest that among treatment completers, 86% of patients receiving 
TLC achieved significant symptom relief, defined by a 50% or greater reduction in 
Beck Depression Inventory (BDI-II, Beck, Steer, & Brown, 1996) scores, compared 
with 33% of patients in the control group (Karwoski, 2006). To date, however, TLC 
has not been adapted for use as a preventive intervention. 
The Need for Brief Preventive Interventions 
There is a paucity of brief, inexpensive, and practical preventive programs for 
patients at risk for depression, especially given shrinking health-care budgets 
(D’Amico & Fromme, 2002; Ludman et al., 2000). Traditional methods of prevention 




Intensive resources are needed to provide both maintenance medication (with 
monthly follow-up visits) and psychotherapy, even if sessions are relatively few and 
“brief” (e.g., eight weekly sessions for two hours each, Seligman et al., 1999). 
Conventional preventive pharmacotherapy and psychotherapy require frequent in-
person meetings with specialty providers, making them expensive and logistically 
impractical for large populations – particularly for schools, which are often 
overburdened with academic curriculum demands (Essau, 2004). The cost of 
preventive interventions will always be a factor in terms of feasibility. A costly, time-
consuming, comprehensive intervention is unlikely to be widely adopted, not only 
due to strained resources, but also because recipients do not want to make the 
necessary commitment (Muñoz & Ying, 1993). 
For a subset of vulnerable individuals, acute interventions using therapeutic 
approaches such as CT, IPT, and mindfulness have proven to confer enduring 
protection against the future onset of depression. However, these interventions are 
somewhat lengthy and expensive, and are therefore potentially unrealistic for use with 
large populations of at-risk individuals (e.g., university students). Moreover, it would 
be quite challenging to effectively convey the principles of any of these therapy 
protocols in a brief preventive-intervention format. For example, Clarke et al. 
(Clarke, Hawkins, Murphy, & Sheeber, 1993) attempted to use behavioral strategies 
using a five-session preventive protocol in an adolescent population. They found no 
outcome differences between adolescents who received the intervention and those 




and costly to be acceptable in most settings, Clarke and colleagues suggested that the 
approach with the greatest likelihood of both experimental success and adoption in 
real-life settings is perhaps the promotion of general healthy living skills. When it 
comes to the formulation of brief preventive interventions, education regarding basic 
lifestyle changes would appear to represent a promising, cost-effective approach, 
especially if non-experts (e.g., educators, registered nurses, etc.) could easily 
administer such a protocol. This strategy also supports the emerging approach of 
shifting the focus of intervention for depressed individuals from the prevention of 
relapse to the maintenance of health (Dobson & Ottenbreit, 2004). 
Traditional preventive strategies are often implemented as add-ons to ongoing 
acute-phase treatments. As such, they occur in the context of existing therapeutic 
relationships – which generally are not available for high-risk individuals who have 
not yet experienced a full-blown depressive episode. In addition, some at-risk 
individuals will lack motivation to complete any preventive intervention that requires 
a significant time commitment. Someone with a history of depression but no ongoing 
symptomatology, for example, may not be inspired to seek out extensive treatment. 
Likewise, an individual who is currently experiencing mild symptoms, but who has 
never experienced a full episode, may not realize the potentially dangerous territory 
that could lie ahead. For each of the aforementioned reasons, traditional preventive 
interventions – which tend to be lengthy and expensive – are generally impractical for 
individuals who are not in the painful, treatment-seeking state of a major depression 




it is likely to yield the highest possible health benefit at the lowest possible cost 
(Smit, Beekman, Cuijpers, de Graaf, & Vollebergh, 2004). 
Supporting Evidence for Brief Interventions 
Short-term intervention strategies can sometimes be equally effective as 
longer-term strategies (Miller & Barber, 2002). Specifically, extremely brief (single-
session), educational, behaviorally-oriented interventions have successfully modified 
such difficult-to-change behaviors as adolescent risk-taking (D’Amico & Fromme, 
2002) and substance use (Grenard et al., 2007; Martin, Copeland, & Swift, 2005), 
ineffective contraception use among women (Ingersoll et al., 2005), excessive alcohol 
use among college students (e.g., Ehrlich, Haque, Swisher-McClure, & Helmkamp, 
2006; for a review, see Larimer et al., 2004), smoking among mothers (Yilmaz, 
Karacan, Yöney, & Yilmaz, 2006), gambling (Hodgins, 2005), infrequent seat belt 
use (Pastò & Baker, 2001), insufficient dietary intake of fruits and vegetables 
(Marcus et al., 2001), and physical inactivity among sedentary working women 
(Purath et al., 2004). 
There exist no published data, however, on the use of a single-session 
psychoeduational intervention to specifically prevent depression. Self-described 
“brief” interventions targeting depression typically provide between four and fifteen 
sessions (e.g., Cole & Dendukuri, 2004; Dorwick et al., 2000; Lang, 2003). However, 
several relevant studies of remarkably simple, pithy interventions provide convincing 




Willemse and colleagues (Willemse, Smit, Cuijpers, & Tiemens, 2004), for 
example, tested the efficacy of a “minimal-contact” therapeutic intervention for 
subclinically depressed individuals. The main component of the intervention was a 
self-help manual with instructions on CBT skills for mood management. The manual 
also included homework assignments and was augmented by an in-person interview 
with a specialist and six short telephone calls (maximum 15 minutes each). At a one-
year follow-up (Smit et al., 2006), the incidence of major depression among 
participants who received the intervention was reduced by a third in comparison with 
the control condition (12% versus 18%). 
Ludman and colleagues (2000) conducted what they described as a “low 
intensity” preventive program targeting patients at high risk of depression relapse. 
Participants received two thirty-minute videos and a book about recurrent depression, 
two 60-90 minute sessions with a prevention specialist, an assignment to write a 
personalized relapse prevention plan, bimonthly meetings with a psychiatrist for one 
year, follow-up phone consultations, and written personalized feedback. A majority 
of participants attended both in-person meetings (93%), completed all three telephone 
calls (80%), returned at least one feedback form (85%; 48% returned all four forms), 
suggesting that such an intervention is feasible. Participants receiving the preventive 
program had significantly greater adherence to adequate dosage of antidepressants 
and were more likely to refill prescriptions. At a one-year follow-up, treatment group 
participants showed significantly fewer depressive symptoms than the control group, 




Van Voorhees and colleagues (Van Voorhees, Ellis, Stuart, Fogel, & Ford, 
2005) tested an internet-based depression prevention for at-risk late adolescents. 
Participants had at least one risk factor for developing depression (family history or a 
past depressive episode) and many were experiencing subclinical depressive 
symptoms. The intervention included an initial motivational interview, web-based 
modules based on CBT and IPT concepts, and a follow-up motivational interview. 
Acceptability of the study was good: 100% of participants completed the initial 
interview, 13/14 used the website, and 8/14 completed the follow-up interview. 
Changes in depressive symptoms, dysfunctional thinking, and social support showed 
favorable, though not statistically significant, trends among completers. 
Lang (2003) evaluated the effectiveness of a four-session cognitive-behavioral 
intervention for co-occurring anxiety and depression. Participants in the treatment 
condition received four weekly sessions for their symptoms. The intervention led to 
statistically significant reductions in symptoms across multiple measures of 
depression and functioning. The relief in depressive symptoms in particular was 
maintained over a one-month follow-up period, indicating that a relatively brief 
intervention can successfully treat acute depressive suffering. 
 Finally, Han et al. (2006) conducted very brief (5-10 minute) single-session 
interventions with college students. Interventions were designed to enhance either 
biological knowledge regarding depression, encourage destigmatization of seeking 
treatment for depression, or a combination of both. All three treatment conditions 




regarding depression. The authors suggested that flyers with similar information 
could successfully be used in a community setting, at least with individuals with a 
college-level education. 
 Although results from these extremely brief interventions are generally not as 
strong as results from lengthier preventive programs, they do show promise. There 
exist many large-scale settings where more costly and intensive interventions are 
simply not feasible, but the risk of depression is very real – such as the college 
environment. In this sort of location, a single-session intervention may be one of the 
few realistic ways to inexpensively but effectively reach many at-risk individuals. 
The Present Study 
The present study aims to test a novel approach to the prevention of 
depression: a psychoeducational intervention with a focus upon basic lifestyle 
changes. This approach was designed in response to the need for brief, inexpensive, 
acceptable, time-efficient, and easily implemented interventions. It was also designed 
based on an evolutionary theoretical model of depression that significantly differs 
from other psychological and medical models. For this reason, other interventions 
such as cognitive therapy, mindfulness, etc. will not be included. Participants will 
enroll in a single one-hour group psychoeducational session that covers all six 
primary TLC elements. In conjunction, they will be given several handouts and a 
website address, which will provide further information and details about the TLC 
elements and their utility as a means of preventing depression onset. The six key 




contemporary life (Ilardi et al., 2009) and appear to be effective as an acute treatment 
for MDD (Karwoski, 2006). It is hypothesized that they will also be effective at 
prevention. 
The proposed study intervention can be classified both as a secondary and a 
tertiary prevention effort, and, more specifically, both a selective and an indicated 
program. In other words, this study will target college students who have suffered at 
least one major depressive episode in the past and are currently suffering from 
subclinical depression. Both factors are clear risks for the development of a full 
depressive episode (e.g., Gotlib, Lewinsohn, & Seeley, 1995; Horwath et al. 1992; 
Lewinsohn et al., 1988; Paykel et al., 1995; Pintor et al., 2001) and thus are 
appropriate targets of a preventive intervention. 
Prevention is particularly relevant for at-risk college students in light of two 
additional considerations: (a) the increased threat of depression onset faced by 
younger cohorts, and (b) the high level of depressogenic stress that characterizes the 
college environment. 
Younger Cohorts at Risk 
As noted previously, the prevalence of depression is increasing over time 
(Seligman, 1990). There is a higher rate of both major depression and subclinical 
depression among younger generational cohorts (Kessler & Walters, 1998). 
Moreover, the age of onset for the initial depressive episode is younger for each 
successive cohort (Klerman et al., 1985). Colla and colleagues (Colla, Buka, 




relationship between age and depression. First, being younger involves greater 
conflict over modernization issues, such as figuring out one’s role in the family 
versus in the larger society. Second, when older generations were younger, the 
upheavals of modernization had not gone forward enough to create much 
psychological disturbance, and these individuals progressed to older age without 
many prior depressive episodes. This hypothesis is a promising one and relates to an 
evolutionary model of depression. 
More than half of all individuals who will suffer from depression experience 
the first onset of the disorder – the initial episode – by age 25 (Sorenson, Rutter, & 
Aneshensel, 1991). In fact, being in one’s teens or twenties is regarded as a primary 
risk factor for the onset of depression (Lewinsohn, Hoberman, & Rosenbaum, 1988), 
and one quarter of young adults in their teens and twenties have already suffered an 
episode of MDD (Kessler & Walters, 1998; Kessler et al., 2003). Preventing 
depression in young people is extremely important, and effective interventions carry 
the potential to decrease the chance of premature death due to suicide, reduce future 
health care costs, and, of course, increase quality of life far into the future (Lynch et 
al., 2005). 
Stressful College Environment 
Early stress (stress that occurs in early adulthood) is considered a major risk 
factor for the onset of a depressive episode. A person’s first major depressive episode 
typically occurs in mid- to late adolescence (Hammen, 2001), and early episodes of 




fact, according to the diathesis-stress model of depression, without some sort of 
significant life stressor, even at-risk individuals are not especially likely to become 
depressed (Beck, 1967; Beck, 1983). For some college students, especially freshmen, 
the college environment can be extremely stressful. These young adults typically 
undergo a great deal of adjustment in the transition to college. Some of them 
encounter many, if not all, of the major stressors believed to precipitate bouts of 
depression (Vredenburg, Flett, & Krames, 1993): they have recently moved away 
from home for the first time, left behind their families and many of their closest 
friends, feel pressure to succeed academically in more difficult coursework, find 
themselves surrounded by thousands of other students, and may wind up feeling 
socially isolated and lonely (Petersen, Compas, & Brooks-Gunn, 1992). 
A recent study of 1,455 college students from four universities found that 53% 
of participants experienced what they would label as depression during their time at 
college (Furr, Westefeld, McConnell, & Jenkins, 2001). Significant costs for 
institutions of higher education are incurred through untreated depression in students 
(Levine & Cureton, 1998). The National Mental Health Association suggested that 
colleges and universities would benefit from programs for prevention and early 
detection of depression (Field, Elliott, & Korn, 2006). To that end, researchers have 
created community-based interventions for the prevention of depression designed to 
reach broad groups of students (Field et al., 2006). Schools are an overlooked 
resource in combating the depression epidemic, but are important, especially because 




campuses offer abundant opportunities to implement both screenings and 
interventions (Larimer, Cronce, Lee, & Kilmer, 2004). 
Although some researchers have argued against the use of college students in 
depression research (e.g., Coyne & Gotlib, 1983; Gotlib, 1984), Vredenburg and 
colleagues (1993) reviewed the existing literature and concluded that studies with 
college samples are worthwhile. The frequent stressors encountered in the college 
environment make students an important target for intervention, and there is no 
compelling evidence that depression in college students is significantly different from 
depression in psychiatric populations. In fact, college populations are particularly 
appropriate for investigations into the early development of depression and an 
important target for intervention efforts (Hart et al., 2001) for several reasons. First, 
the college environment is relatively homogeneous, and students have a high 
likelihood of encountering multiple stressful life events that tend to predict the onset 
of depression. It is important to target populations that are specifically at high risk for 
the development of depression at the time of the intervention or within the proximal 
future (Cardemil & Barber, 2001). Second, there is a reduced risk of other psychiatric 
disorders in college students that could interfere with or account for research findings. 
Third, depression has a profound impact on disinterest in school and can lead to 
impaired academic performance (Heiligenstein, Guenther, Hsu, & Herman, 1996). 
Fourth, the danger of suicide is 50% higher among college students than among non-




typically do not seek help for depression (Vredenburg, O’Brian, & Krames, 1988), 
they are in need of intervention. 
Summary of Study Hypotheses 
Past research points to a high risk of MDD onset among individuals who are 
subclinically depressed or who have experienced a past depressive episode (e.g., 
Coyne et al., 1999; Judd et al., 1998).  There is some evidence, however, that this risk 
can be attenuated on the basis of preventive psychosocial interventions (Bockting et 
al. 2005; de Mello et al., 2005; Ma & Teasdale, 2004; Rafanelli, Park, & Giovanni, 
1999) as well as adherence to protective lifestyle factors such as exercise 
(Paffenbarger et al., 1994) and dietary omega-3 consumption (Stoll et al., 1999).  
Although there has not yet appeared a published evaluation of a single-session 
preventive intervention for depression, single-session interventions have already 
proven successful in inducing behavior change and thereby reducing the risk for other 
adverse clinical outcomes such as excessive alcohol use (Larimer et al., 2004) and 
risk-taking behaviors (D’Amico & Fromme, 2002). Accordingly, the principal 
hypotheses of the present study were as follows:  
(1) a single one-hour psychoeducational TLC intervention will be sufficient to 
induce significantly greater adoption of protective lifestyle factors than those 





(2) participants who receive the preventive TLC intervention will be less 
likely to experience the onset of a major depressive episode than will controls 
at both the two-month and six-month follow-up evaluations; and  
(3) participants who report greater adoption of protective lifestyle elements 
should be less likely to experience a major depressive episode than 






 The study included 107 partial completers over the course of two years (four 
academic semesters). Participants were undergraduate students enrolled in an 
introductory psychology course at the University of Kansas. On the basis of 
information gathered in two self-report measures and a clinical interview, all 
participants (a) had experienced a past depressive episode of MDD, according to 
DSM-IV-TR criteria (APA, 2000) and/or (b) met criteria for current minor depressive 
disorder. Individuals who met current criteria for major depressive disorder were not 
included. 
Measures 
 BDI-II.  The Beck Depression Inventory (BDI, Beck et al., 1988), and its 
successor, the BDI-II (Beck et al., 1996), are popular self-report measures designed to 
gauge the severity of depressive symptoms. The BDI-II is a 21-item questionnaire 
designed to measure the presence and severity of symptoms over the past two weeks. 
The Beck measures have been among the most widely used self-report questionnaires 
for depression, and they exhibit high internal consistency, test-retest reliability, and 
construct validity (Whisman, Perez, & Ramel, 2000; Beck et al., 1996; 1988). Some 
prevention researchers have even recommended that the BDI-II be used in all studies 
in depression, as it has become one of the benchmarks against which other outcomes 




Possible scores on the BDI-II lie between 0 and 63. Typically, scores between 
0 and 9 are viewed as normal, while scores between 10 and 20 are associated with 
mild or subclinical depression. Scores of 17 or higher are considered to be possible 
candidates for a diagnosis of MDD (Kendall, Hollon, Beck, Hammen, & Ingram, 
1987). A cutoff score of 15 ensures a high probability that participants not be 
diagnosable with MDD. Thus, participants who scored between 10 and 15 on the 
BDI-II were recruited. 
IDDL.  The Inventory to Diagnose Depression, Lifetime Version (IDDL; 
Zimmerman & Coryell, 1987) is a 22-item self-report measure designed to diagnose 
lifetime history of MDD. It covers the entire range of symptoms used to diagnose 
current or past clinical depression. The IDDL has good internal consistency 
(Cronbach’s α = 0.92), split-half reliability, and test-retest reliability (ĸ=0.77; 
Zimmerman & Coryell), in addition to concordance with the frequently used 
Structured Clinical Interview for DSM-IV Disorders (ĸ=0.75 for the first trial of the 
IDDL and 0.68 for the second trial; Sato et al., 1996), discriminant validity (ĸ =.59 for 
diagnosing lifetime history of major depression), sensitivity (83%), and specificity 
(79%; Sakado, Sato, Uehara, Sato, & Kameda, 1996) in clinical samples. 
There is no specific cut-off score determining the presence of a current or past 
depressive episode on the IDDL. Rather, diagnosis is determined using a series of 
items that match the DSM-IV-TR (APA, 2000) symptom criteria for MDD. Following 
these criteria, to qualify for a likely diagnosis of MDD, individuals must report five or 




one of the symptoms being (a) depressed mood or (b) loss of interest or pleasure. The 
IDDL also asks for the start and end dates of the episode during which individuals felt 
the most depressed, and how many other similar episodes they have experienced. 
Participants who were unlikely to meet criteria for a current depressive episode but 
who were likely to meet criteria for a minor depressive episode (based on BDI-II 
responses) and are likely to have had one or more past major depressive episodes 
(based on IDDL responses) were recruited. The IDDL was used for the first and 
second semesters of recruitment. 
SCID.  The Structured Clinical Interview for DSM-IV Disorders mood module 
(SCID; First, Spitzer, Gibbon, & Willams, 1997) is a widely used structured clinical 
interview used to diagnose current and lifetime Axis I mental disorders, including 
MDD. This is a highly reliable tool and is known as the best diagnostic classification 
instrument to date. Interrater agreement kappas for diagnosing major depression using 
SCID range from .64 to .93 in both community and clinical samples (Segal, Hersen, 
& Van Hasselt, 1994). 
Participants who screened into the study based on BDI-II and IDDL scores 
were invited to come in and undergo only the depression mood module of the SCID. 
They were considered eligible for the study if they met criteria for a past depressive 
episode and current minor depressive disorder. Defining subclinical depression can be 
tricky and is difficult to pin down operationally (Ingram et al., 2004). For the 
purposes of this study, participants were included if they met criteria for minor 




fewer than five symptoms of a major depressive episode, at least one of the symptoms 
being either (a) depressed mood or (b) loss of interest or pleasure (APA, 2000). 
Participants who met criteria for current major depressive disorder were excluded. 
Participants were not screened specifically for anxiety disorders; most 
interventions for depression do not use comorbid anxiety as an exclusionary criterion 
(e.g., DeRubeis et al., 2005). As Kendall and colleagues (1987) point out, consistent 
agreement scores across multiple measurement methods are necessary to secure a 
diagnosis, or lack thereof, of major depression. Thus, although participants were 
screened into the study on the basis of BDI-II and IDDL scores, the SCID determined 
whether they were eligible to continue. If, at the conclusion of the SCID interview, 
participants were not eligible for the intervention, they were not offered the chance to 
participate in the intervention. However, referral sources as described in the below 
section were provided to them upon conclusion of the interview. 
Training for the four SCID interviewers was done by Chantal Young, M.A., 
who was trained by watching the standard SCID training tapes prepared at the New 
York State Psychiatric Institute by First and Gibbon (1996) for DSM-IV, and by 
receiving private training by Dr. Juliet Nelson and performing approximately ten 
interviews under the supervision of Nelson. The four interviewers for this study were 
second or third year graduate students who underwent private training by Young. 
They performed several practice interviews, and then performed approximately 10 
interviews on actual participants with Young in the room. Both Young and the 




to examine any discrepancies. When discrepancies did occasionally arise, they were 
discussed in detail. Interviewers continued to perform interviews under supervision 
until inter-rater concordance with Young was near 100%. 
TLC Adherence Questionnaire.  An adherence questionnaire (see Appendix 
A) measured compliance with TLC lifestyle elements by asking participants about the 
degree to which they are following each element. Both treatment and control group 
participants completed this questionnaire, because it is feasible that those in the 
control group may have implemented TLC elements on their own. Mixed in with 
questions about TLC elements was a set of “distractor” questions about other lifestyle 
domains unrelated to TLC, included in order to prevent the control group from 
realizing the nature of study hypotheses. 
Social Support Measure.  Included in the TLC Adherence Questionnaire was a 
20-item measure assessing participants’ available social support resources and 
openness to receiving social support, based on prior questionnaires assessing social 
support (Folkman & Lazarus, 1980; McGrath, Gutierrez, & Valadez, 2000; Sarason, 
Levine, Basham, & Sarason, 1983; Sarason, Sarason, Shearin, & Pierce, 1987; Vaux, 
1985; Vaux, A., Riedel, S., & Stewart, D., 1987). The Social Support Measure 
included two categories of social support: emotional and instrumental (Carver, 
Scheier, & Weintraub, 1989; Cutrona, 1990; Florian, Mikulincer, & Bucholtz, 1995; 
Slavin, 1991). Within these categories, three types of support were included: 
perceived, actively sought, and passively accepted, derived from past research 




Gracia, 2007; Srivastava & Singh, 2006; Vitaliano, Russo, Carr, Maiuro, & Becker, 
1985; Zimet, Dahlem, Zimet, & Farley, 1988). Sample items included: I seek 
sympathy and understanding from my friends and family (classified as emotional and 
actively sought); I am open to receiving help from other people with day-to-day tasks 
(classified as instrumental and passively accepted). Participants rated each item on a 
7-point scale, ranging from 1 (disagree strongly) to 7 (agree strongly). A total score 
ranging from 0 to 140 was calculated for each participant. 
Adherence Metric.  Six adherence variables, one for each TLC element, were 
created. Adherence variables reflected participants’ proportional adherence 
(percentage) with respect to the target goal for each element. Target goals as 
presented in the psychoeducational presentation were as follows: for fish oil, the 
recommended dosage was at least 6 pills per day (at a per-pill dose of 180mg EPA); 
for cardiovascular exercise, at least 1.5 hours per week of aerobic activity; for 
sunlight exposure, at least 60 minutes per day; for social support, as little time as 
possible spent alone (operationalized as at most one non-sleeping hour alone per day); 
for anti-rumination, as little time as possible spent ruminating (operationalized as zero 
hours ruminating per day). 
 Adherence for fish oil supplementation was calculated as the mean number of 
pills per day divided by six. For exercise, it was the mean number of hours of 
cardiovascular exercise per week divided by 1.5. To derive a measure of adherence to 
sunlight exposure, the mean minutes of exposure to sunlight or artificial bright light 




company of others1 was divided by the number of waking hours. For anti-rumination, 
the mean number of hours spent ruminating per day was subtracted from the number 
of waking hours per day, and the difference was divided by the number of waking 
hours. All adherence percentages were capped at 100%, and participants were not 
penalized for exceeding recommended dosages. 
Procedure 
Recruitment 
Introductory psychology students were recruited to take part in the study as 
partial fulfillment of course requirements. They completed an online mass screening 
questionnaire that asks about current and past depressive symptoms, using questions 
adapted from the BDI-II and IDDL. Based on these self-report measures, selected 
participants were unlikely to meet criteria for MDD, but were likely to be in the midst 
of a subclinical depressive episode and/or have a history of past major depressive 
disorder. Prospective participants were contacted via a method they indicate as most 
convenient (e-mail or telephone) and invited to enlist in the study. 
Participants were then evaluated in person to verify eligibility by Chantal 
Young, M.A. or another trained graduate-level research assistant. Eligibility was 
verified through verbal completion of the portion of the SCID depression module that 
assesses current and past depression. Participants were selected if they met criteria for 
current minor depressive disorder and/or had a history of major depressive episodes, 
                                                
1 The social support adherence variable was adjusted to allow for one hour of alone 




but did not meet current criteria for MDD. If participants were eligible, they filled out 
the TLC adherence questionnaire and BDI-II at that time. 
Upon conclusion of the in-person evaluation, participants were randomly 
assigned to either the treatment or control group. Participants assigned to the 
treatment condition were invited to fulfill further course credit by participating in a 
one-hour educational session and a subsequent two-month follow-up session. 
Participants assigned to the control condition were invited to participate in a two-
month follow-up session, also for course credit. 
Treatment Group 
Sixty participants were randomly assigned to the treatment group. Random 
assignment was achieved by using a random number generator to assign each 
participant a number between 1 and 100. Those who received numbers between 1 and 
50 were assigned to the treatment group, and those with numbers between 51 and 100 
were assigned to the control group. Those assigned to the treatment group attended a 
one-hour psychoeducational session on the antidepressant value of TLC lifestyle 
elements. This session was a highly condensed, streamlined version (see Appendix B) 
of the original 12-week protocol for treating acute depression (Ilardi et al., 2009). The 
sessions were run in groups of four to eight participants and were led by Chantal 
Young, M.A. or another trained graduate-level research assistant. Details of the 
session are reviewed in this section. 
The session began with an introduction. Participants were informed that their 




were assured that they would not be required to share any personal information with 
the group, but if they chose to do so, everything would be kept confidential. All group 
members were asked not to share any personal information with anyone outside of the 
group. 
The session moved on to a brief overview of the symptoms of depression, 
with an emphasis on the recurrent nature of depression, danger of relapse, and 
subclinical symptoms as a precursor to full-blown MDD (approximately 15 minutes). 
This information was included because depression is a long-term problem, and 
researchers argue that it is important to teach individuals how to recognize the early 
symptoms and encourage them to help themselves at the earliest signs of clinical 
change (Franchini et al., 1999). Although low mood in and of itself is not necessarily 
maladaptive (Keller & Nesse, 2005), in at-risk individuals it can lead to major 
depression, which is an enormously debilitating problem. Participants were advised to 
watch for signs of extreme decline in mood. They were then informed of the purpose 
of the session, which was to teach skills that have been shown to help prevent the 
onset of major depression. 
The session continued to an explanation of the evolutionary “mismatch” 
hypothesis (Ilardi et al., 2009). Participants were asked to consider the vast 
differences between modern and ancestral lifestyles, and were provided a summary of 





Next, participants were given an outline of the six TLC lifestyle elements that 
are believed to be antidepressant in nature: physical exercise, dietary omega-3 fatty 
acids, sunlight exposure, sleep, social support, and anti-ruminative activity 
(remaining 30 minutes). Participants were given specifics for each TLC element, 
including a brief theoretical explanation of their functions in mental health, followed 
by precise “dosage” information. They were given supplementary handouts with 
replication of the same material that was given verbally (see Appendix C). They were 
also encouraged to visit the TLC website for further information. Finally, they were 
asked to fill out a goal sheet with their current usage of TLC elements and their 
personal goals for the semester, following the presentation (see Appendix D). They 
were instructed to keep these goal sheets for themselves. 
Questions and clarifications were welcomed and answered as thoroughly as 
possible, given time constraints. Upon conclusion of the hour, participants were 
invited to stay longer on their own time if they had further questions or would like to 
hear more about the theoretical background of the materials presented. They were 
provided with and encouraged to use additional referral sources, including contact 
information for the KU Psychological Clinic, a 24-hour suicide hotline, and multiple 
private psychotherapists in the Lawrence area. Before leaving, participants signed up 
for two- and six-month follow-up meetings. 
Website.  Treatment group participants were given the address to the TLC 
website. This website provides detailed information about major depressive disorder 




depression. Participants had access to the website on their own time, at any hour of 
the day, so that the intervention could be reinforced through this ongoing material. 
Conveying information passively through written and online materials is not only less 
expensive, but also increases the feasibility of the intervention because greater contact 
is maintained with clients in their natural environments (Muñoz, 1993). There is 
evidence that internet-based preventive measures for depression are effective, 
especially when paired with in-person elements (Van Voorhees et al., 2005). 
Control Group 
Forty-one participants were randomly assigned to an assessment-only control 
group. They were provided with and encouraged to use the same referral sources 
given to the treatment group participants. They signed up for a two-month follow-up 
upon conclusion of the initial interview, and a six-month follow-up upon conclusion 
of the two-month follow-up. At the six-month follow-up, control group participants 
were fully informed of the potential benefit of TLC elements. They were also given 
the handouts on TLC that were given to the treatment group participants, and 
encouraged to visit the TLC website for further information. 
Follow-Up Assessments 
All participants were invited to participate in two-month and six-month 
follow-up meetings. Because the two-month follow-up fell before the end of the 
semester, partial course credit was given in exchange for completion. However, 
because the six-month follow-up was beyond the end of the semester, participants 




$100 were given away at the end of the study. At both follow-ups, participants were 
re-administered the module of the SCID assessing current MDD, the BDI-II, and the 
adherence questionnaire. If for any reason participants were unable to come in for the 
six-month follow-up in person, they were mailed the BDI-II and adherence 
questionnaire and asked to return them in a prepaid envelope. They were also re-
administered the module of the SCID assessing current MDD over the phone. Past 
research shows that telephone assessments of major depression using the SCID have 
good agreement with in-person interviews (ĸ=.64, Cacciola, Alterman, Rutherford, 
McKay, & May, 1999; ĸ=.73, Simon, Revicki, & VonKorff, 1993) and are acceptable 
to interviewees (Allen, Cull, & Sharpe, 2003). The follow-ups took approximately 20 
minutes per person. 
Consent and Confidentiality 
All participants gave informed consent for each step in the study. They were 
informed that they were free to withdraw from the study without penalty and that they 
would be given credit for every half hour they spent on the study (excluding the six-
month follow-up, for which they received enrollment in the raffle). They were 
assured that all information they shared, both verbally and on questionnaires, would 
be kept confidential. Participants were given debriefing forms at the conclusion of the 






An initial sample of 406 prospective participants was screened to take part in 
the study, of which 173 were deemed eligible on the basis of meeting DSM-IV-TR 
(APA, 2000) diagnostic criteria for either a past major depressive episode or a current 
minor depressive episode (or both). All eligible participants were randomized into 
one of two conditions: 97 (56%) were assigned to the study’s treatment group, and 76 
were assigned (44%) to the control group.  Among these randomized participants, 107 
(aged 18-37 years, mean = 19.5; 67 women, 40 men) attended at least one follow-up 
session, and were therefore included in the primary study analyses. Of the 107 
individuals included in these principal analyses, 60 had been assigned to the treatment 
condition, and 47 to the control condition. These two resulting groups did not differ 
significantly2 (all p>.05) with respect to sex, age, year in school, race, baseline BDI-II 
scores, experience of a current minor depressive episode or a past major depressive 
episode, current use of psychotherapy or psychotropic medications, or pre-study 
adherence to TLC healthy lifestyle factors (see Table 1). 
Retention 
As noted, 107 (62%) of 173 eligible participants returned for at least one 
follow-up. Fisher’s exact test revealed no significant difference in retention between  
 
                                                
2Categorical variables were analyzed using either a chi-square analysis with Yates’ 
correction (Preacher, 2001) or a Fisher’s exact test (Preacher & Briggs, 2001). 






Baseline comparison of treatment and control groups 
 
            Treatment            Control      Total        Fisher’s exact test p 
 
Sex 
Male             43.3% (26)         29.8% (14)        37.4% (40)               .16 
Female         56.7% (34)         70.2% (33)        62.6% (67) 
Presence of current minor depressive episode 
 Yes               46.7% (28)         63.8% (30)        54.2% (58)            .08 
 No                53.3% (32)         36.2% (17)        45.8% (49) 
Experience of past major depressive episode 
 Yes               73.3% (44)         68.1% (32)       71.0% (76)            .67 
 No                26.7% (16)         31.9% (15)       29.0% (31) 
Currently in psychotherapy 
 Yes                10.0% (6)            4.3% (2)    7.5% (8)            .46 
 No                90.0% (54)         95.7% (45)  92.5% (99) 
Currently using psychotropic medications 
 Yes               13.3% (8) 10.6% (5)  12.1% (13)            .77 




Table 1, cont. 
 
                                 Treatment            Control      Total              χ2        df         p 
 
Year in school 
Freshman        63.3% (38)        57.4% (27)       60.7% (65)       .14     3       .99 
Sophomore     25.0% (15)   25.5% (12)       25.2% (27) 
Junior             11.7% (7)   14.9% (7)         13.1% (14) 
Senior               0.0% (0)     2.1% (1)           0.9% (1) 
 
Race/ethnicity 
 Caucasian       81.7% (49)   87.2% (41)       84.1% (90)       .23     7     1.00 
 Latino-Am.       6.7% (4)     4.3% (2)           5.6% (6) 
 Asian-Am.        3.3% (2)     4.3% (2)           3.7% (4) 
African-Am.     1.7% (1)     0.0% (0)           0.9% (1) 
Native Am.        1.7% (1)     0.0% (0)           0.9% (1) 
Bi-/Multicult.    1.7% (1)            0.0% (0)           0.9% (1) 
International      1.7% (1)     4.3% (2)           2.8% (3) 




Table 1, cont. 
 
                                 Treatment        Control       Total          F           t           df        p 
 
Age 
Mean     19.16   19.80          19.45 5.56     -1.19       99     .24 
Range     18-29   18-37          18-37 
 SD       1.74     3.54           2.70 
Baseline BDI-II score 
Mean     11.65   11.38          11.53  1.37   0.17   105    .87 
 Range      0-33                 1-36           0-36      
 SD      8.46                 7.87            8.17 
Baseline sleep adherence 
Mean            87.03%            83.51%       85.48%  2.52   1.22   105    .23
 Range          56-100%           0-100%      0-100% 
 SD    11.87               17.89          14.85 
Baseline social support adherence 
Mean            81.12%            81.65%       81.35%    .28    -.16   103 .88 
 Range          17-100%           0-100%      0-100% 




Table 1, cont. 
 
                                 Treatment        Control       Total          F           t           df        p 
 
Baseline fish oil adherence 
Mean                5.14%           5.67%         5.37%        .28   -.17   105    .86 
 Range                0-67%           0-100%      0-100% 
 SD                13.12   18.80          17.07 
Baseline sunlight exposure adherence 
Mean              74.93%         87.01%       79.98%      9.71 -1.87   101    .07 
 Range              0-100%         0-100%       0-100% 
 SD                35.75   26.92          32.76 
Baseline exercise adherence 
Mean              76.84%         75.89%       76.42%   .00   -.12  104 .90 
 Range              0-100%        0-100%      0-100% 
 SD                 39.76   39.75          39.57 
Baseline anti-rumination adherence 
Mean             91.97%          91.19%       91.64%   .03    .42  102    .68 
 Range           42-100%        61-100%     42-100% 
 SD                  9.78     8.76            9.34 
 




treatment groups: 60 participants (61%) were retained in the treatment group and 47 
participants (62%) in the control group (p>.05). 
Within both the treatment and control groups, comparisons showed no 
significant differences between participants who returned and those who did not on 
the basis of sex, age, year in school, race, baseline BDI-II scores, presence of a 
current minor depressive episode or a past major depressive episode, psychotherapy 
participation, psychotropic medication use, or pre-study adherence to TLC healthy 
lifestyle factors (see Tables 2 and 3). 
Among the 107 participants included in main analyses, 42 (39%) were 
considered partial completers because they attended only the two-month follow-up 
(41) or only the six-month follow-up (1), while 65 (61%) were considered full 
completers because they attended both follow-up sessions. Of participants in the 
treatment group, 60 (100%) completed the two-month follow-up, and 42 (70%) 
completed the six-month follow-up. Of participants in the control group, 46 (98%) 
completed the two-month follow-up, and 24 (51%) completed the six-month follow-
up. 
Adherence variables 
 Six adherence variables, one for each TLC element, were created for the 
purpose of study analyses. These variables reflected participants’ proportional 
adherence (on a percentage basis) with respect to the target behavioral goal for each 
respective element. For example, for fish oil, the target dosage (as suggested in the 





Baseline comparison of treatment group participants who returned and those who did 
not return 
 
            Returned         Did not return      Total        Fisher’s exact test p 
 
Sex 
Male            43.3% (26)         35.1% (13)        40.2% (39)               .52 
Female         56.7% (34)        64.9% (24)        59.8% (58) 
Presence of current minor depressive episode 
 Yes              46.7% (28)         59.5% (22)        51.5% (50)           .30 
 No               53.3% (32)         40.5% (15)        48.5% (47) 
Experience of past major depressive episode 
 Yes              73.3% (44)         62.2% (23)        69.1% (67 )           .27 
 No               26.7% (16)         37.8% (14)        30.9% (30) 
Currently in psychotherapy 
 Yes              10.0% (6)           12.1% (4)  10.8% (10)           .74 
 No               90.0% (54)         87.9% (29)  89.2% (83) 
Currently using psychotropic medications 
 Yes              13.3% (8)  9.1% (3)  11.8% (11)           .74 




Table 2, cont. 
 
                                Returned        Did not return      Total              χ2        df         p 
 
Year in school 
Freshman        63.3% (38)      69.7% (23)        65.6% (61)       .40     3       .94 
Sophomore     25.0% (15)      21.2% (7)          23.7% (22) 
Junior             11.7% (7)   6.1% (2)            9.7% (9) 
Senior               0.0% (0)   3.0% (1)            1.1% (1) 
 
Race/ethnicity 
 Caucasian       81.7% (49)      84.8% (28)        82.8% (77)       .85     7     1.00 
 Latino-Am.       6.7% (4)   6.1% (2)            6.5% (6) 
 Asian-Am.        3.3% (2)          3.0% (1)            3.2% (3) 
African-Am.     1.7% (1)   0.0% (0)           1.2% (1) 
Native Am.       1.7% (1)   3.0% (1)           2.2% (2) 
Bi-/Multicult.    1.7% (1)          0.0% (0)            1.2% (1) 
International      1.7% (1)   3.0% (1)            2.2% (2) 




Table 2, cont. 
 
                              Returned       Did not return     Total         F           t          df       p 
 
Age 
Mean  19.16             19.61            19.32    2.61      -.77      85    .44 
Range             18-29             18-38            18-38 
 SD    1.74               3.71              2.60 
Baseline BDI-II score 
Mean  11.65             14.54              12.72     .02   -1.59    93     .12 
 Range    0-33               0-34              0-34      
 SD    8.46               8.69              8.62 
Baseline sleep adherence 
Mean          87.03%          87.88%         87.33%     .02    -.33    91     .75
 Range        56-100%          0-100%         0-100% 
 SD             11.87             12.30            11.97 
Baseline social support adherence 
Mean          81.12%          75.17%         79.07%    2.83    1.48    88 .14 
 Range        17-100%          0-100%         0-100% 




Table 2, cont. 
 
                              Returned       Did not return     Total         F           t           df       p 
 
Baseline fish oil adherence 
Mean            5.14%              5.67%            5.29%       .34    -.13    91     .90 
 Range             0-67%            0-100%          0-100% 
 SD             13.12             18.48             15.14 
Baseline sunlight exposure adherence 
Mean          74.93%            85.78%          78.55%     6.72  -1.48    88    .14 
 Range           0-100%          17-100%          0-100% 
 SD             35.75             25.67             32.99 
Baseline exercise adherence 
Mean          76.84%            70.71%           74.64%    1.71     .68    90 .50 
 Range           0-100%            0-100%          0-100% 
 SD             39.76             44.69             41.45 
Baseline anti-rumination adherence 
Mean          91.97%            87.82%           90.56%     .62    1.92    89     .06 
 Range         42-100%         63-100%         42-100% 
 SD               9.78               9.76               9.92 
 





Baseline comparison of control group participants who returned and those who did 
not return 
 
            Returned         Did not return      Total        Fisher’s exact test p 
 
Sex 
Male            30.4% (14)         31.0% (9)         30.3% (23)              1.00 
Female        69.6% (33)         69.0% (20)       69.7% (53) 
Presence of current minor depressive episode 
 Yes              63.8% (30)         62.2% (18)       63.2% (48)              1.00 
 No               36.2% (17)         37.9% (11)       36.8% (28) 
Experience of past major depressive episode 
 Yes              68.1% (32)         75.9% (22)       70.1% (54)            .60 
 No               31.9% (15)         24.1% (7)         29.9% (23) 
Currently in psychotherapy 
 Yes              33.3% (2)          65.2% (45)   8.0% (6)            .19 
 No               66.7% (4)          87.9% (29)        92.0% (69) 
Currently using psychotropic medications 
 Yes              10.6% (5)           28.6% (8) 17.3% (13)            .06 




Table 3, cont. 
 
                                   Returned        Did not return        Total            χ2        df         p 
 
Year in school 
Freshman           57.4% (27)       71.4% (20)       62.7% (47)     3.14     3       .37 
Sophomore        25.5% (12)     28.6% (8)         26.7% (20) 
Junior            14.9% (7)       0.0% (0)           9.3% (7) 
Senior                  2.1% (1)       0.0% (0)           1.3% (1) 
 
Race/ethnicity 
 Caucasian           85.4% (41)     85.74% (24)      85.5% (65)      .68     5      .98 
 Latino-Am.          4.2% (2)       3.6% (1)           3.9% (3) 
 Asian-Am.           4.2% (2)       0.0% (0)           2.6% (2) 
African-Am.        0.0% (0)       3.6% (1)           1.3% (1) 
Native Am.          0.0% (0)        0.0% (0)          0.0% (0) 
Bi-/Multi-cult.     0.0% (0)        0.0% (0)          0.0% (0) 
International        4.2% (2)        3.6% (1)          3.9% (3) 




Table 3, cont. 
 
                              Returned       Did not return     Total         F           t          df       p 
 
Age 
Mean             19.80             18.69            19.39    5.16     1.55     69    .13 
Range             18-37             18-23            18-37 
 SD    3.54               1.09              2.93 
Baseline BDI-II score 
Mean             11.38             11.12            11.28    2.13       .13     74 .90 
 Range    1-36               0-37              0-37      
 SD    7.87               9.45              8.45 
Baseline sleep adherence 
Mean          83.51%          90.85%          86.25%    2.36    -1.96     7    .054
 Range          0-100%        63-100%          0-100% 
 SD  17.89            11.09            16.02 
Baseline social support adherence 
Mean          81.65%          80.95%          81.38%    5.16     1.55    69 .13 
 Range          0-100%           25-97%          0-100% 




Table 3, cont. 
 
                              Returned       Did not return     Total         F           t           df       p 
 
Baseline fish oil adherence 
Mean            5.67%             9.23%            7.00%   1.43    -.74    73     .46 
 Range          0-100%            0-100%           0-100% 
 SD            18.80             22.15               20.04 
Baseline sunlight exposure adherence 
Mean          87.02%           84.12%          85.87%     .28     .45      69     .66 
 Range          0-100%           7-100%         0-100% 
 SD            26.92             26.83             26.73 
Baseline exercise adherence 
Mean          75.89%           88.10%          80.44%   9.88  -1.47    73     .15 
 Range          0-100%           0-100%         0-100% 
 SD            39.75             24.37            35.13 
Baseline anti-rumination adherence 
Mean          91.19%           89.78%          90.65%   3.09     .55    69     .59 
 Range         61-100%          45-100%       45-100% 
 SD              8.76              12.95             10.48 
 




a participant who reported taking six pills per day would be 100% adherent; a 
participant who reported taking three pills per day would be 50% adherent. Target  
goals for the other TLC elements were as follows: exercise, 1.5 hours per week; 
sunlight exposure, 60 minutes per day; social support, one hour alone per day (at 
most); anti-rumination, zero hours ruminating per day; sleep, eight hours per night. 
Effect of TLC treatment on TLC adherence 
 The first study hypothesis was that the one-hour psychoeducational TLC 
intervention would be sufficient to induce significantly greater adoption of protective 
lifestyle factors than those observed among the no-intervention control condition. To 
test this hypothesis, six 2x2 repeated measures ANOVAs were conducted to compare 
initial adherence to TLC elements to adherence at the two-month follow-up (see 
Table 4A). There was a significant main effect of treatment group on adherence to 
fish oil supplementation, F(1,103) = 8.05, p<.01, and a significant time-by-treatment 
interaction effect for fish oil, as well, F(1,103) = 16.11, p<.001. In addition, there 
were observed trends for greater sleep adherence in the treatment group, F(1,104) = 
3.52, p=.06, and for a time-by-interaction effect for social support, F(1, 101) = 3.38, 
p=.069. There was no significant effect of treatment group on adherence to the 
remaining TLC elements (exercise, sunlight exposure, and anti-rumination), nor were 
any other significant time-by-treatment interaction effects observed. 
Follow-up t-tests were conducted to evaluate mean differences in adherence to 






Effect of treatment condition on TLC adherence at two- and six-month follow-ups        
                                                     Two-month follow-up 
Adherence variables                      MS         F                p        df 
Sleep 
 Treatment group        1366.34           3.52  .06      104 
Time            113.17       1.33  .25 
Time * Treatment group         166.24       1.95  .16 
Social support 
 Treatment group           121.85            .28  .60      101 
 Time             3.68         .03  .88  
Time * Treatment group          504.28          3.38            .069 
Fish oil 
 Treatment group         5383.71           8.05**         .005      103 
 Time           4677.69         12.07**         .001 
Time * Treatment group        6243.83         16.11**         .000 
Sunlight exposure 
Treatment group        5760.38           4.30*  .04        98
 Time             149.13         .19  .67 






Table 4A, cont. 
                                                     Two-month follow-up 
Adherence variables                      MS         F                p        df 
Exercise 
 Treatment group          569.60             .23  .63           101
 Time          1775.86       2.01            .16 
Time * Treatment group           28.29         .03  .86 
Anti-rumination 
 Treatment Group            35.25             .29  .59           100
 Time            164.80       3.84            .053 
Time * Treatment group               .43         .01            .92 
 
                                                     Six-month follow-up 
Adherence variables                      MS         F                p        df 
Sleep 
Treatment group        1096.58           3.64  .06             63
 Time            360.81       3.44  .07 
Time * Treatment group         194.95       1.86  .18 
Social 
Treatment group              5.12             .02  .88             63
 Time            506.92       2.96            .09 




Table 4A, cont. 
                                                     Six-month follow-up 
Adherence variables                      MS         F                p        df 
Fish oil 
Treatment group        3819.87           4.88*            .03           61
 Time          3554.69       7.35**          .009 
Time * Treatment group       3783.96       7.82**          .007 
Sunlight exposure 
Treatment group        3067.26           2.04            .16             61 
 Time            419.62         .53            .47 
Time * Treatment group           .64         .001          .98 
Exercise 
Treatment group          306.13             .14  .71             62
 Time            630.21         .63            .43 
Time * Treatment group         421.88         .42            .52 
Anti-rumination 
Treatment group            .12             .001          .98           60
 Time              .30         .002          .97 







TLC adherence among treatment groups at two- and six-month follow-ups 
    
    Two months                     Six months 
      Treatment         Control        Treatment           Control 
 
Sleep 
Mean    87.34%*       80.43%*          89.94%*          86.46%* 
SD    13.00              19.03          12.09            12.18 
Social support 
Mean     84.37       79.85%               86.58%          85.11% 
SD    10.90                   23.06          11.84          12.59 
Fish oil 
Mean    25.69%*         4.44%*         27.14%*            4.51%* 
SD    34.73                   16.05                  37.35                20.41 
Sunlight exposure 
Mean    73.71%        84.03%          70.67%          81.70% 
SD    32.64                   31.62          33.61               31.76 
Exercise 
Mean    72.31%        68.89%          74.39%            76.39% 







Table 4B, cont. 
   
    Two months                     Six months 
                      Treatment         Control        Treatment           Control 
 
Anti-rumination 
Mean    93.70%        91.37%               92.55%           91.97% 
SD      6.95                   13.23          15.77           11.98 




As expected, there was a significant between-group difference at the two-
month follow-up regarding adherence to fish oil, t(103) = 35.96, p<.001, but not at 
the initial screening, t(105) = .86, p=.86. Participants in the treatment group had an 
average fish oil adherence of 25.69% (SD=34.73) at two months, while participants in 
the control group had an adherence of 4.44% (SD=16.05). Also as expected, there 
was a significant difference between the treatment and control groups at the two-
month follow-up in adherence to sleep, t(104) = 2.23, p<.05, but not at the initial 
screening, t(104) = 1.15, p=.26. Participants in the treatment group had an average 
sleep adherence of 87.34% (SD=13.00) at two months, while participants in the 
control group had an adherence of 80.43% (SD=19.03). For social support adherence, 
no significant difference was found between groups at either the initial screening, 
t(102) = -.16, p=.87, or two month follow-up, t(103) = 1.13, p=.19. 
 A second set of six 2x2 repeated measures ANOVAs was conducted to 
compare initial adherence to reported adherence at the six-month follow-up (see 
Table 4A). There was again a significant main effect of treatment group on fish oil 
supplementation, F(1,61) = 4.88, p<.05, as well as a significant time-by-treatment 
interaction effect for fish oil, F(1,61) = 7.82, p<.01. In addition, there was a trend for 
greater sleep adherence in the treatment group, F(1,63) = 3.64, p=.06. No significant 
main effect of treatment group was observed regarding adherence to the remaining 
TLC elements (sunlight exposure, exercise, social support, and anti-rumination), nor 




Follow-up t-tests tests were conducted to evaluate mean differences in 
adherence to fish oil and sleep (see Table 4B for means and standard deviations). As 
expected, there was a significant difference between the treatment and control groups 
at the six-month follow-up in adherence to fish oil, t(63) = 2.87, p<.01, but not at the 
initial screening, t(64) = -.08, p=.94. Participants in the treatment group had an 
average fish oil adherence of 31.55% (SD=38.72) at six months, while participants in 
the control group had an adherence of 6.52% (SD=21.17). Also as expected, there 
was a significant difference in adherence to sleep, t(63) = 2.76, p<.01. Participants in 
the treatment group had an average sleep adherence of 88.62% (SD=11.59) at six 
months, while participants in the control group had an adherence of 77.17% 
(SD=21.95). 
Effect of TLC treatment on depression risk 
 The second study hypothesis was that participants who received the 
preventive TLC intervention would be less likely to experience the onset of clinically 
significant depression. Participants were evaluated for major and minor depressive 
episodes at two- and six-month follow-ups. Fisher’s exact tests were conducted to 
determine whether the percentage of participants who experienced the onset of 
depression differed at the time of follow-up. At two months, the onset of both major 
and minor depression differed significantly by treatment group (see Table 5). In the 
control group, 17.8% (n=8) of participants met criteria for major depression, versus 






Risk of depression in treatment vs. control groups at two- and six-month follow-ups 
                                       Treatment         Control       Fisher’s 
              exact test p 
Two-month follow-up 
 Major depression                           1.7% (1)        17.4% (8)           .005 
 No major depression                         98.3% (59)      82.2% (37) 
 Minor depression                                28.3% (17)      56.5% (26)         .005 
 No minor depression                          72.7% (43)      43.5% (20) 
Six-month follow-up 
 Depression-spectrum disorder            12.2% (5)        33.3% (8)           .056 
 No depression-spectrum disorder       87.8% (36)      66.7% (16) 
Note. Major and minor depression were combined for the six-month follow-up 




 met criteria for minor depression, versus only 28.3% (n=17) of the treatment group 
(p<.01). 
Due to the relatively small number of participants available for the six-month 
analyses, those with either major or minor depression were combined into a single 
“depression spectrum” group for analytic purposes. At six months, there was a trend 
for the experience the onset of a depression-spectrum disorder significantly differing 
by treatment group. In the control group, 33.3% (n=8) of participants met criteria for 
either major or minor depression, versus only 12.2% (n=5) in the treatment group 
(p=.056). 
 Based on these significant findings, logistic regressions were conducted to test 
whether the TLC intervention decreased the risk of depression at the time of the 
follow-ups, even when controlling statistically for the effect of clinical status at the 
pre-intervention baseline (BDI-II scores, presence of current minor depression, and 
experience of past major depression). Treatment group significantly predicted the 
presence of depression at both two and six months (see Table 6). At two months, 
participants in the control group were 13.23 times more likely than participants in the 
control group to have experienced the onset of major depression (p<.05), and 3.15 
times more likely to have experienced the onset of minor depression (p<.01). At six 
months, participants in the control group were 4.74 times more likely than 
participants in the treatment group to have experienced the onset of a depression-






Comparison of depression risk in treatment and control groups, controlling for 
baseline depression variables 
 
 
                        β           SE β      Wald’s χ2       p       Exp(β) 
 
Two-month follow-up:  Major depression    
Treatment group                              2.58         1.12   5.31**      .02         13.23 
Baseline BDI-II                                .07           .05   1.99          .16           1.07 
Baseline current minor depression            .62           .96            .41        .52           1.86 
Baseline past major depression               1.51         1.13          1.79          .18           4.52 
 
Two-month follow-up:  Minor depression 
Treatment group                              1.15           .43          7.04**      .008        3.15 
Baseline BDI-II          .03           .03   1.19        .27           1.03 
Baseline current minor depression        .84           .49   2.86          .09           2.31 




Table 6, cont. 
 
 
                        β           SE β      Wald’s χ2       p       Exp(β) 
 
Six-month follow-up:  Depression spectrum 
Treatment group        1.56           .72          4.70*        .03           4.74 
Baseline BDI-II          .10           .05     3.8          .051         1.11 
Baseline current minor depression       -.78           .81     .94          .33             .46 






In order to test for between-group differences in severity of depressive 
symptoms, mean BDI-II scores were evaluated for the treatment and control groups at 
two months (treatment M=9.55, SD=8.94 and control M=10.76, SD=8.59) and six 
months (treatment M=8.22, SD=7.30 and control M=7.98, SD=5.76). Unexpectedly, t-
tests revealed no significant differences in BDI-II scores between treatment groups at 
either two months, t(104) = -.70, p=.48, or six months, t(63) = .14, p=.89. 
 Regarding whether baseline variables predicted depression onset, results 
revealed a trend for BDI-II scores at the initial screening significantly predicting a 
depression-spectrum disorder at the six-month follow-up (p=.051; see Table 6). None 
of the other baseline variables predicted either minor or major depression risk at 
either the two- or six-month follow-ups. 
Effect of TLC adherence on depression risk 
 The third study hypothesis was that participants who adhered to TLC elements 
(regardless of their assigned treatment condition) would be less likely to experience 
an onset of depression. At two months, participants who did not meet criteria for 
major depression were observed to be more likely to adhere to both anti-rumination, 
t(101) = 56.95, p<.001, and exercise goals, t(101) = .70, p<.05, at the time of follow-
up. There was also a trend for greater adherence to social support goals, t(102) = .23, 
p=.057. Participants who did not meet criteria for minor depression were more likely 
to be adhering to anti-rumination, t(102) = 5.01, p<.05, and sleep goals, t(104) = 2.89, 
p<.05, at the time of follow-up. There was also a trend for greater adherence to 




related to presence of major or minor depression at either two or six months (see 
Table 7). 
 Associations between adherence variables and BDI-II scores at two- and six-
month follow-ups were also evaluated. At two months, BDI-II scores were 
significantly negatively correlated with adherence to sleep, r(106) = -.27, p< .01, 
exercise, r(104) = -.22, p< .05, and anti-rumination, r(104) = -.52, p< .05. At six 
months, BDI-II scores were significantly negatively correlated with adherence to 
sleep, r(65) = -.26, p< .05, and anti-rumination, r(63) = -.37, p< .01 (see Table 8). 
Exploratory analyses of adherence 
TLC adherence.  In addition to the primary items used to assess adherence to 
TLC elements, eleven other questions were asked of participants as secondary 
measures of adherence (see Table 9). Accordingly, 2x2 repeated measures ANOVAs 
were conducted to compare the treatment and control groups on initial adherence to 
the exploratory variables versus adherence at the two-month follow-up. There was a 
significant main effect of treatment group on the number of fish oil pills taken daily, 
F(1,103) = 8.34, p<.01. In addition, a significant time-by-treatment interaction effect 
was found for number of fish oil pills, F(1,103) = 14.91, p<.001. As expected, a 
follow-up t-test showed a significant difference between the treatment and control 
groups at the two-month follow-up in number of pills taken, t(103)=3.69, p<.001, but 
not at the initial screening, t(104)= -.211, p=.83. Participants in the treatment group 
took an average of 1.66 pills per day (SD=2.38) at two months, while participants in 





Comparison of mean TLC adherence in participants with and without minor and 
major depression at two- and six-month follow-ups  
   Two-month follow-up 
                   Major depression 
                         Yes                 No 
Adherence variables        Mean        SD  Mean        SD      t           df         p 
Sleep                            76.39%    21.14        84.99%    15.64      -1.53       103      .13 
Social support                71.61%    17.49        83.60%    16.90      -1.92       102      .057 
Fish oil                  8.33%    17.82        17.45%    30.95        -.82       102      .41 
Sunlight exposure    75.28%    34.70        78.16%    32.51        -.25       100      .80 
Exercise                37.04%    45.47        73.76%    41.15      -2.54*     101      .02 
Anti-rumination    74.62%    24.25        94.23%      6.16      -6.12**   101      .000 
 
   Two-month follow-up 
                   Minor depression 
                         Yes                 No 
Adherence variables        Mean        SD  Mean        SD      t           df         p 
Sleep                            80.38%    19.27        87.05%    13.19      -2.12*     104      .04 
Social support                79.88%    22.97        84.14%    11.95      -1.24       103      .22 
Fish oil                13.49%    27.85        18.65%    31.53        -.86       103      .39 
Sunlight exposure    83.19%    29.61        74.77%    29.61       1.29       101      .20 
Exercise                60.98%    45.89        77.25%    39.18      -1.93       102      .056 





Table 7, cont. 
    Six-month follow-up 
                   Major depression 
                         Yes                 No 
Adherence variables        Mean        SD  Mean        SD      t            df         p 
Sleep                            81.25%      6.25        89.01%    12.28      -1.08         63       .28 
Social support                89.49%      5.97        83.60%    16.90          .51        63       .62 
Fish oil                  5.56%      9.62        19.17%    34.32         -.68        61       .50 
Sunlight exposure    75.00%    25.00        74.62%    33.64          .02        62       .99 
Exercise                55.56%    76.08        50.92%    36.79        - .93        63       .36 
Anti-rumination    90.44%      6.08        92.43%    14.72         -.23        61       .82 
     
    Six-month follow-up 
                   Minor depression 
                         Yes                 No 
Adherence variables        Mean        SD  Mean        SD      t           df         p 
Sleep                            83.17%    13.35        90.02%    11.56      -1.85        63       .07 
Social support                89.12%    12.50        85.27%    11.93       1.03         63      .31 
Fish oil                17.31%    37.03        18.83%    33.11        -.14        61       .89 
Sunlight exposure    68.65%    37.92        76.16%    32.04        -.73        62      .47 
Exercise                69.23%    41.86        76.60%    36.34        -.64        63      .53 







Correlations between TLC adherence and BDI-II scores at two- and six-month 
follow-ups 
          Pearson correlation with BDI-II  p  N 
Sleep adherence 
 Two months                              -.27**             .005           106 
 Six months                              -.26*             .04             65 
Social support adherence 
 Two months                              -.15              .12           105 
 Six months                              -.10              .46             65 
Fish oil adherence 
 Two months                              -.04              .66           106 
 Six months                              -.08              .50             66        
Sunlight exposure adherence 
 Two months                              .02              .84           103 
 Six months                             -.16              .22             64 
Exercise adherence    
 Two months                             -.22*             .03           104 







Table 8, cont. 
          Pearson correlation with BDI-II  p  N 
 
Anti-rumination adherence    
  Two months                              -.52**             .000           104 









Effect of treatment condition on exploratory TLC adherence variables at two- and 
six-month follow-ups 
                                                     Two-month follow-up 
Adherence variables                      MS         F                p        df 
Hours per day spent in company of others 
Treatment group          6.75             .14  .71       102 
Time              38.71       2.93            .09 
Time * Treatment group           21.89       1.66            .20 
Number of social activities per week 
 Treatment group            42.34       1.18  .28       101 
Time              22.90       1.11  .29 
Time * Treatment group           16.48         .80            .37 
Number of phone calls to people you care about per week 
 Treatment group            92.20         .40            .53       102 
Time            142.32       1.28  .26 
Time * Treatment group               .03         .000  .99 
Social Support Measure 
Treatment group        1446.05       1.97  .16        94 
Time          1012.69     12.05**        .001 




Table 9, cont. 
                                                     Two-month follow-up 
Adherence variables                      MS         F                p        df 
Minutes per day spent outside during daytime hours 
 Treatment group      10316.72       2.16            .15       102 
Time            540.49         .17            .68 
Time * Treatment group       4599.10       1.43  .24 
Hours per week spent on weight training/strengthening exercises 
 Treatment group            .13         .02            .90       102 
Time              .05         .01            .91    
Time * Treatment group           .30         .08            .78 
Number of pleasurable, fun activities per week 
Treatment group          127.14       3.13  .08        97 
Time                  .98         .05  .83 
Time * Treatment group           .28         .01  .91 
Hours per week spent on pleasurable, fun activities 
 Treatment group            33.66         .25  .62       102 
Time              27.49         .62  .43 







Table 9, cont. 
                                                     Two-month follow-up 
Adherence variables                      MS         F                p        df 
Minutes needed to fall asleep 
 Treatment group          177.85        .16  .69       103 
Time            301.79        .69  .41 
Time * Treatment group       1385.53      3.16  .08 
Number of times waking up during the night 
Treatment group          3.58         .53            .47       103 
Time              12.01       2.52  .12 
Time * Treatment group           15.56       3.26  .07 
Number of fish oil pills taken per day 
 Treatment group            23.24       8.34**          .005       103 
Time              20.45     11.45**          .001 




Table 9, cont. 
                                                     Six-month follow-up 
Adherence variables                      MS         F                p        df 
Hours per day spent in company of others 
Treatment group              1.77         .04  .84        63 
Time            1.39         .13  .73 
Time * Treatment group         1.24         .11  .74 
Number of social activities per week 
 Treatment group            19.78         .43  .52        61 
Time              21.18         .76  .39 
Time * Treatment group           41.30       1.49  .23 
Number of phone calls to people you care about per week 
 Treatment group            45.94         .16            .69        63 
Time            262.09       2.03  .16 
Time * Treatment group         109.78         .85  .36 
Social Support Measure 
Treatment group        3235.97           6.16*           .02        57 
Time          1680.83     12.01**        .001 







Table 9, cont. 
                                                     Six-month follow-up 
Adherence variables                      MS         F                p        df 
Minutes per day spent outside during daytime hours 
 Treatment group      26098.57       3.93          .052        63 
Time            541.92         .09            .76 
Time * Treatment group         299.92         .05  .82 
Hours per week spent on weight training/strengthening exercises 
 Treatment group                .01       .002  .96        63 
Time                1.22         .49  .49 
Time * Treatment group           .01       .002  .96 
Number of pleasurable, fun activities per week 
Treatment group            43.90         .67  .42        59 
Time            4.03         .20  .66 
Time * Treatment group           .45         .02  .88 
Hours per week spent on pleasurable, fun activities 
 Treatment group            80.00         .70  .41        63 
Time            124.64       1.31  .26 







Table 9, cont. 
                                                     Six-month follow-up 
Adherence variables                      MS         F                p        df 
Minutes needed to fall asleep 
 Treatment group        1630.48       2.10  .15        63 
Time              19.54         .12  .73 
Time * Treatment group         355.86       2.25  .14 
Number of times waking up during the night 
Treatment group              3.09         .34  .57        62 
Time              14.18       2.10  .15 
Time * Treatment group           14.18       2.10  .15 
Number of fish oil pills taken per day 
 Treatment group            14.54       4.96*   .03        61 
Time              13.56       7.27**         .009 






At two months, there was a significant main effect of time on the Social 
Support Measure, a 20-item measure (possible scores from 0-140) designed to  
evaluate participants’ amount of, and willingness to utilize, social support resources, 
F(1,94) = 12.05, p<.01. At the initial meeting, participants had an average Social 
Support Measure score of 99.48 (SD=20.35), whereas at the two-month follow-up, 
participants had an average score of 105.05 (SD=21.32). There was no significant 
main effect of treatment group on the Social Support Measure or any of the 
remaining exploratory variables, nor were any other significant time-by-treatment 
interaction effects observed. 
A second set of 2x2 repeated measures ANOVAs was conducted comparing 
the treatment and control groups on initial adherence to the exploratory variables 
versus adherence at the six-month follow-up. There was a significant main effect of 
treatment group on the number of fish oil pills taken daily, F(1,61) = 4.96, p<.05. In 
addition, a significant interaction effect was found for number of fish oil pills, F(1,61) 
= 7.72, p<.001. As expected, a follow-up t-test showed a significant difference 
between the treatment and control groups at the six-month follow-up in number of 
pills taken, t(61) = 3.11, p<.01, but not at the initial screening, t(64) = -.08, p=.94. 
Participants in the treatment group took an average of 1.67 pills per day (SD=.66) at 
six months, while participants in the control group took an average of .27 pills per 
day (SD=1.23). 
At six months, there was also a significant main effect of treatment group on 




group had an average Social Support Measure score of 110.60 (SD=17.29) at six 
months, while participants in the control group had an average score of 101.27 
(SD=13.27).There was no significant effect of treatment group on adherence to any of 
the remaining exploratory variables, nor were any other significant time-by-treatment 
interaction effects observed. 
In addition to the primary exploratory variables described above, which were 
continuous in nature, eight categorical exploratory variables were examined for their 
relationship to treatment group, using Fisher’s exact tests. At two months, the 
following items were significantly related to treatment group, in the direction of the 
treatment group having greater adherence: Do you take an omega-3 (fish oil) 
supplement? (p<.001), Do you feel sleepy during the day? (p<.05). At six months, the 
following items were significantly related to treatment group, in the direction of the 
treatment group having greater adherence: Do you take an omega-3 (fish oil) 
supplement? (p<.001), Do you often wake up in the middle of the night?, (p<.05). 
Depression risk.  Exploratory TLC adherence variables were also analyzed for 
their relationship to depression risk (see Table 10). At two months, participants who 
met criteria for major depression were more likely to report needing more time to fall 
asleep at night, t(102) = 2.08, p<.05, and engaging in fewer social activities per week, 
t(101) = -2.14, p<.05, at the time of follow-up. Participants who met criteria for minor 
depression at the two-month follow-up were more likely to report waking up more 






Comparison of exploratory TLC adherence variables in participants with and without 
minor and major depression at two- and six-month follow-ups  
   Two-month follow-up 
                   Major depression 
                         Yes                 No 
Adherence variables        Mean        SD  Mean        SD      t           df          p 
 
Hours per day spent in company of others 
                              5.06         4.32           7.42       5.44        -1.27      103       .21 
Number of social activities per week 
                              2.33         2.01           4.94       3.59        -2.14*    101       .04 
Number of phone calls to people you care about per week 
                              6.67         7.65         10.66     14.08          -.84      103       .41 
Social Support Measure 
                             96.33      17.46       106.08     20.63        -1.37        97       .18 
Minutes per day spent outside during daytime hours 
                             68.89       53.08        73.72     61.06          -.23      102       .82 
Hours per week spent on weight training/strengthening exercises 
                              1.39         2.32          1.45        2.76          -.07      101       .95 
Number of pleasurable, fun activities per week 





Table 10, cont. 
   Two-month follow-up 
                   Major depression 
                         Yes                 No 
Adherence variables        Mean        SD  Mean        SD      t           df          p 
 
Hours per week spent on pleasurable, fun activities 
                              9.61         8.30        10.68        9.83          -.32      102       .75 
Minutes needed to fall asleep 
                             44.11      35.91        25.17      24.86         2.08*     102      .04 
Number of times waking up during the night 
                              1.78         1.28          1.24        1.32         1.16      103       .25 
Number of fish oil pills taken per day 
                                .50         1.07          1.12        2.08          -.83      102       .41 
 
   Two-month follow-up 
                   Minor depression 
                         Yes                 No 
Adherence variables        Mean        SD  Mean        SD      t           df          p 
 
Hours per day spent in company of others 
                              7.28         6.39          7.19        4.57           .83      104       .93 
Number of social activities per week 




Table 10, cont. 
   Two-month follow-up 
                   Minor depression 
                         Yes                 No 
Adherence variables        Mean        SD  Mean        SD      t           df          p 
Number of phone calls to people you care about per week 
                              9.16         9.31         11.17      15.92         -.74      104       .46 
Social Support Measure 
                            99.71       24.19       108.86      16.47       -2.25*       98      .03           
Minutes per day spent outside during daytime hours 
                            73.04       55.87         73.50      62.89         -.04       103       .97 
Hours per week spent on weight training/strengthening exercises 
                              1.49         2.63          1.46        2.79           .05       102       .96 
Number of pleasurable, fun activities per week 
                              6.67         6.36          7.21        4.55          -.51      101       .61 
Hours per week spent on pleasurable, fun activities 
                              9.41         7.05        11.34      11.08        -1.01      103       .32 
Minutes needed to fall asleep 
                            32.35       27.57        23.25      24.81         1.76      103       .08 
Number of times waking up during the night 
                              1.73         1.19            .99        1.32         2.95**  104       .004 
Number of fish oil pills taken per day 




Table 10, cont. 
    Six-month follow-up 
                Depression spectrum 
                         Yes                 No 
Adherence variables        Mean        SD  Mean        SD      t           df          p 
 
Hours per day spent in company of others 
                              7.50         4.93          8.63        4.82           .75        63       .46 
Number of social activities per week 
                              5.08         1.98          4.82        3.67          -.24        61       .81 
Number of phone calls to people you care about per week 
                              6.42         5.77          9.73        9.93         1.15        62       .26 
Social Support Measure 
                              5.06         4.32          7.42        5.44         2.24*      60       .03 
Minutes per day spent outside during daytime hours 
                            98.00        15.21      109.52      16.14          .45        63       .66 
Hours per week spent on weight training/strengthening exercises 
                                 .77           .95          1.22        1.60           .96        63       .34 
Number of pleasurable, fun activities per week 
                            10.38         9.74          7.06        5.22        -1.68        61       .10 
Hours per week spent on pleasurable, fun activities 





Table 10, cont. 
    Six-month follow-up 
                Depression spectrum 
                         Yes                 No 
Adherence variables        Mean        SD  Mean        SD      t           df          p 
 
Minutes needed to fall asleep 
                            34.85       24.19        23.97      18.49        -1.78        63       .08 
Number of times waking up during the night 
                              1.58           .89          1.32        1.22          -.70        62       .49 
Number of fish oil pills taken per day 






Measure, t(98) = -2.25, p<.05. Due to the relatively small number of participants 
available for the six-month analyses, those with either major or minor depression 
were combined into a single “depression spectrum” group for analytic purposes. At 
six months, participants who did not meet criteria for a depression-spectrum disorder 
were more likely to score higher on the Social Support Measure, t(60) = -2.24, p<.05. 
 Associations between exploratory TLC adherence variables and BDI-II scores 
at two- and six-month follow-ups were also evaluated (see Table 11). At two months, 
BDI-II scores were significantly negatively correlated with hours per day spent in the 
company of others, r(104) = -.21, p< .05, and the Social Support Measure, r(101) = -
.29, p< .01, and significantly positively correlated with minutes needed to fall asleep, 
r(106) = -.20, p< .05. At six months, BDI-II scores were significantly positively 
correlated with number of times waking up during the night, r(64) = .27, p< .05. 
In addition to the primary exploratory variables, which were continuous in 
nature, eight categorical exploratory variables were examined for their relationship to 
depression risk, using Yates’ corrected chi-square or Fisher’s exact tests (see Table 
12). At two months, the following items were significantly related to depression risk, 
in the direction of the non-depressed participants having greater adherence: Is your 
sleep restful?, χ2 (2) = 8.74, p<.05, Do you often wake up in the middle of the night?, 
χ2 (2) = 12.00, p<.01, Do you exercise on a regular basis?, χ2 (2) = 6.41 p<.05, Do 
you find yourself ruminating often?, χ2 (2) = 8.75, p<.05, Is it easy for you to stop 
ruminating?, χ2 (2) = 8.58, p<.01. Due to the relatively small number of participants 





Correlations between exploratory TLC adherence variables and BDI-II scores at two- 
and six-month follow-ups 
          Pearson correlation with BDI-II  p  N 
Hours per day spent in company of others 
 Two months                              -.21*             .03           104 
 Six months                              -.08              .55             65 
Number of social activities per week 
 Two months                              -.12              .21           104 
 Six months                              -.14              .29             63 
Number of phone calls to people you care about per week 
 Two months                              -.09              .34           104 
 Six months                               .16              .20             64        
Social Support Measure 
 Two months                              -.29**             .003           101 
 Six months                              -.20              .12             62 
Minutes per day spent outside during daytime hours 
 Two months                              -.09              .34           101 
 Six months                               .05              .63             65 
Hours per week spent on weight training/strengthening exercises 
  Two months                               .03             .75           105 




Table 11, cont. 
          Pearson correlation with BDI-II  p  N 
Number of pleasurable, fun activities per week 
 Two months                              -.18              .08           100 
 Six months                               .03              .79             63        
Hours per week spent on pleasurable, fun activities 
 Two months                              -.17              .08           104 
 Six months                               .04              .74             65        
Minutes needed to fall asleep 
 Two months                               .20*             .04           106 
 Six months                               .12              .35             65        
Number of times waking up during the night 
 Two months                              -.02              .82           105 
 Six months                               .27*             .03             64       
Number of fish oil pills taken per day 
 Two months                               .03              .77           106 








Comparison of exploratory TLC adherence variables in participants with no 
depression, minor depression, and major depression at two- and six-month follow-ups 
   Two-month follow-up 
Adherence variables        No depr.       Minor depr.       Major depr.          χ2         p 
Do you take an omega-3 (fish oil) supplement? 
     Yes/Sometimes        31.7% (19)    28.6% (10)         7.1% (2)         .02       .99 
     No                68.3% (41)    71.4% (41)         92.9% (26) 
Is your sleep restful? 
     Yes/Sometimes        96.61% (57)    74.29% (26)       87.5% (7)       8.74*     .01 
     No                  3.39% (2)    25.71% (9)       12.5% (1) 
Do you feel sleepy during the day? 
     Yes/Sometimes        89.8% (53)    97.1% (34)     100.0% (9)         .96       .62 
     No                10.2% (6)           2.9% (1)         0.0% (0) 
Do you often wake up in the middle of the night? 
     Yes/Sometimes        45.0% (27)    82.9% (29)       75.0% (6)     12.00**    .002 
     No                55.0% (33)       17.1% (6)       25.0% (2) 
If so, are you able to fall asleep again quickly? 
     Yes/Sometimes        91.2% (31)    85.2% (23)       83.3% (5)         .19       .91 






Table 12, cont. 
   Two-month follow-up 
Adherence variables        No depr.       Minor depr.       Major depr.          χ2         p 
Do you exercise on a regular basis? 
     Yes/Sometimes        76.7% (46)    57.1% (20)       33.3% (3)       6.41*     .04 
     No                23.3% (14)    42.9% (15)       66.7% (6) 
Do you find yourself “ruminating” (thinking negatively) often? 
     Yes/Sometimes        49.2% (29)    74.3% (26)     100.0% (8)       8.75*     .01 
     No                50.8% (30)    25.7% (9)         0.0% (0) 
If so, is it easy for you to stop ruminating? 
     Yes/Sometimes        82.4% (28)    63.0% (17)       33.3% (3)       8.58*     .04 
     No                17.6% (6)    37.0% (10)       66.7% (6) 
   Six-month follow-up 
Adherence variables        No depression     Depression spectrum   Fisher’s exact test p 
Do you take an omega-3 (fish oil) supplement? 
     Yes/Sometimes            30.8% (16)      30.8% (4)                     1.00 
     No                    69.2% (36)                 69.2% (9)        
Is your sleep restful? 
     Yes/Sometimes            88.5% (46)       84.6% (11)                      .66 






Table 12, cont. 
   Six-month follow-up 
Adherence variables        No depression     Depression spectrum   Fisher’s exact test p 
Do you feel sleepy during the day? 
     Yes/Sometimes            90.4% (47)       91.7% (11)                      .73 
     No                      9.6% (5)                      8.3% (1) 
Do you often wake up in the middle of the night? 
     Yes/Sometimes            57.7% (30)       76.9% (10)                      .34 
     No                    42.3% (22)                  23.1% (3) 
If so, are you able to fall asleep again quickly? 
     Yes/Sometimes            97.0% (32)       77.8% (7)             .11 
     No                    30.0% (1)        22.2% (2) 
Do you exercise on a regular basis? 
     Yes/Sometimes            73.1% (38)       91.7% (11)           .49 
     No                    26.9% (14)                    8.3% (2) 
Do you find yourself “ruminating” (thinking negatively) often? 
     Yes/Sometimes            51.9% (27)     100.0% (12)                      .002** 
     No                    48.1% (25)                    0.0% (0)  
If so, is it easy for you to stop ruminating? 
     Yes/Sometimes            84.8% (28)       76.9% (10)                      .67 







were combined into a single “depression spectrum” group for analytic purposes. At 
six months, the following item was significantly related to depression risk, in the  
direction of the non-depressed participants having greater adherence: Do you find 
yourself ruminating often?, χ2 (2) = 6.29, p<.01. 
Self-report measure of adherence.  Finally, treatment group participants were 
asked to provide a set of global ratings of how well they believed they adhered to 
each of the TLC elements suggested in the psychoeducational presentation (rating 
themselves from 1 to 5; 1 being no adherence, 5 being perfect adherence). These 
global adherence scores were analyzed to determine whether participants’ self-
reported adherence was correlated with risk for onset of depression. None of the 
adherence scores were significantly associated with onset of either major or minor 
depression, at either two or six months. As a more subtle measure of depressive 
symptoms, BDI-II scores at two- and six-month follow-ups were evaluated using 
correlations. None of the self-report global adherence scores were significantly 





 This study aimed to test the efficacy of a brief intervention for the prevention 
of depression among college students at high risk for depression by virtue of a prior 
history of the illness or elevated (sub-clinical) symptomatology. Treatment group 
participants attended a one-hour psychoeducational session based on an acute group-
based intervention for depression, Therapeutic Lifestyle Change (TLC; Ilardi et al., 
2009), that targets six modifiable lifestyle factors (omega-3 supplementation, social 
support, physical exercise, sunlight exposure, healthy sleep, and anti-rumination 
strategies) useful in the treatment and prevention of depression (Ilardi, 2009; 
Karwoski, 2006). As hypothesized, study participants who received the TLC-based 
intervention were significantly less likely than were control participants to report the 
experience of clinically significant depression at either the two-month or six-month 
follow-up assessments.  
 In logistic regression models that controlled statistically for the effect of 
depressive symptoms and clinical status at the pre-intervention baseline, participants 
who received the study intervention were found substantially less likely than study 
controls to report the experience of either a major or minor depressive episode. At the 
two-month follow-up, those in the intervention group had an estimated 13-fold 
reduction in the risk of major depression diagnosis, and a 3-fold reduction in the risk 
of minor depression. At the six-month follow-up, their estimated odds of 
experiencing a depressive episode (either major or minor) were 4.74 times lower than 




Adherence to TLC elements 
What mediated the apparent reduction in depression vulnerability associated 
with the TLC intervention? In order to help address this question, post-intervention 
adherence to each TLC element was examined to determine the degree to which 
participants incorporated the recommended preventive lifestyle strategies. At both 
two- and six-month follow-ups, treatment group participants were found more likely 
than control group participants to report adherence to two of the six core TLC 
elements: taking fish oil supplements and obtaining adequate sleep. Further, at the 
six-month follow-up, treatment group participants had a higher mean score on the 
Social Support Measure, which reflects utilization of social support resources. It is 
notable that the study’s brief, low-cost preventive intervention – lasting only one hour 
and presented in group format – was capable of inducing enduring behavioral changes 
in this manner. 
Participant adherence to each TLC element was also examined vis-à-vis its 
potential to confer protection from depression risk. At the two-month follow-up, 
participants who adhered to the protocol’s prescribed sleep, exercise, and anti-
rumination goals (regardless of their assigned treatment condition) experienced a 
significant reduction in the risk of both major depression and minor depression. At six 
months, participants who adhered to sleep and anti-rumination goals were again less 
likely to report the experience of depression. Likewise, BDI-II scores were 
significantly negatively correlated with sleep and anti-rumination adherence at both 




Exploratory analyses also revealed several more specific facets of TLC 
protocol adherence that were related to lower depression risk at both follow-ups. At 
two months, these facets included engaging in more social activities, spending more 
time in the company of others, scoring higher on the Social Support Measure, needing 
less time to fall asleep at night, and waking up fewer times during the night. At six 
months, lowered depression risk was related to scoring higher on the Social Support 
Measure. Similarly, BDI-II scores at two months were inversely correlated with 
spending time in the company of others, needing more time to fall asleep, and social 
support. At six months, BDI-II scores were significantly positively correlated only 
with wakeful episodes during the night. 
It is important to note that the observed associations between adherence to 
TLC-based strategies and reduced depression risk could have several possible 
explanations. For example, participants who were more severely depressed over the 
study follow-up period may simply have been less motivated or less energized to 
engage in healthy behaviors. In fact, the absence of some such salubrious behaviors – 
e.g., social contact – may be regarded as a direct manifestation of depressive 
symptomatology. Similarly, it is possible that one or more unmeasured constructs – 
e.g., trait neuroticism, alcohol use, “willpower,” etc. – could have influenced both 
adherence to the targeted lifestyle strategies and to depression risk, thereby yielding 
an artifactual association between the two. Nevertheless, it is certainly possible that 
higher adherence to TLC lifestyle factors directly reduced participants’ risk of 




goals (i.e., obtaining at least 8 hours of sleep per night): treatment group participants 
were not only more likely to obtain adequate sleep over the follow-up period, but sub-
optimal sleep was also significantly related to depression risk at both follow-up time 
points. The study also provided evidence consistent with a protective effect of social 
support. Treatment group participants scored higher on the Social Support Measure at 
the six-month follow-up, and scores on this measure were inversely associated with 
depression vulnerability. Fish oil supplementation, however, was not found to 
decrease depression risk, despite the fact that participants who received the 
intervention clearly consumed more fish oil at both follow-ups. 
Advantages of the TLC Approach 
TLC-based prevention strategies are, at heart, simple behavioral interventions. 
Thus, the clinician’s ability to effectively conduct the psychoeducational TLC group 
session is unlikely to be dependent on a high level of therapeutic skill or experience. 
All four group leaders in the present study were graduate students, three of whom had 
less than one year of psychotherapy experience, and one of whom had no previous 
treatment experience at all. Because the intervention is straightforward, with a clear 
outline and easy-to-follow handouts, it appears amenable to effective implementation 
even by clinicians of modest experience and skill levels. 
It is also notable that the intervention was administered in a group format – a 
relatively low-cost mode of service delivery. Because the psychoeducational session 
was set up like a class, with little, if any, interaction between participants, it should 




freshman orientation at a college or university). And given the paucity of truly brief 
and efficacious preventive programs for individuals at risk for depression, in tandem 
with shrinking health-care budgets (D’Amico & Fromme, 2002; Ludman et al., 
2000), the inherent cost effectiveness of the study’s TLC-based intervention could 
render it a particularly attractive treatment option. Further, unlike some traditional 
strategies for depression prevention – such as cognitive therapy (CT) or mindfulness 
training – which are challenging to present effectively in a single one-hour class, TLC 
strategies lend themselves well to coverage within the constraints of a brief 
presentation format. Thus, the study’s TLC-based intervention may represent a 
promising alternative to existing protocols for the prevention of depression. 
Questions and Concerns 
The most puzzling finding in the present investigation was the absence of a 
statistically significant difference in BDI-II scores between the treatment and control 
groups at either the two-month or six-month follow-ups, despite a significant 
between-group difference in the occurrence of major and minor depression according 
to SCID interviews. Ironically, it was anticipated that BDI scores would provide a 
more sensitive measure of between-group differences in depression symptoms over 
time than would SCID-based diagnoses, since the former are dimensional, and the 
latter categorical. Moreover, BDI-II scores are reasonably strongly correlated with the 
number of depressive symptoms endorsed on the SCID by college students (Sprinkle 




However, there are some respects in which the BDI may be regarded as 
inferior to the SCID – or to any structured diagnostic interview – in the assessment of 
clinical depression (Kendall et al., 1987). First, the BDI was developed as a measure 
of depressive symptom severity, not diagnostic status (Beck et al., 1988; O’Hara, 
Stuart, Gorman, & Wenzel, 2000), and the measure has only modest diagnostic 
specificity (Sloan et al., 2002; Kendall et al., 1987). In fact, it has been argued that the 
BDI is most strongly associated with self-reported distress and malaise, which are 
quite distinct from depression (Coyne, 1994; Pérez & López-Durán, 2005). Steer et 
al. (1998) found that general distress explains approximately 50% of the common 
variance between the Beck self-report anxiety and depression measures, whereas 
unique depression factors only explain approximately 20%. Both high- and low-end 
specificity are of concern, in that high scores can represent constructs other than 
depression, such as other psychological illness (Kendall et al., 1987; Sloan et al., 
2002), while low scores represent underreporting of symptomatology for a significant 
subset of individuals (Joiner, Schmidt, & Metalsky, 1994). It has been recommended, 
therefore, that the BDI serve only as an initial screening tool, rather than a diagnostic 
instrument (Shean & Baldwin, 2008). 
Additionally, several BDI items are not strongly or uniquely related to 
depression (Lovibond & Lovibond, 1995), and BDI scores have been found to be 
strongly correlated with constructs other than depression, such as anxiety, low self-
esteem, situational stress, and general intensity of affect (Andrade, Gorenstein, Vieira 




Gutierrez, & Chiros, 1997; Rudd & Rajab, 1995; Sloan et al., 2002). In general, it is 
considered poor practice to use any self-report measure to diagnose depression, or 
any other psychological disorder (Rudd & Rajab, 1995; Sheeran & Zimmerman, 
2002), even though it is common practice in psychological research (Sloan, 2002). 
 It is possible, therefore, that the study’s TLC-based intervention yielded 
genuine benefit with respect to preventing episodes of major and minor depression, 
despite bringing about no significant reduction in observed scores on the BDI-II. 
While SCID interviews explicitly ask about the simultaneous experience of all 
relevant symptoms over a continuous two-week period during the most recent month, 
BDI scores tend to be based in part on one’s current emotional state (Richter, Werner, 
Heerlein, Kraus, & Sauer, 1998), despite the measure’s purported aim of measuring 
across the most recent two-week interval. Thus, it is feasible that treatment group 
participants successfully used TLC-based strategies to fend off the continuous 
experience of symptoms for two weeks or more, as required for a SCID diagnosis – 
despite being about as likely as control participants to experience temporary distress, 
as indicated by the BDI. Likewise, some treatment group participants may have 
allowed themselves to become temporarily distressed, as indicated by the BDI, after 
which they used TLC strategies to prevent themselves from lapsing into a full-blown 
depressive episode (as indicated by the SCID). 
On the other hand, the aforementioned discrepancy in SCID-based diagnoses 
and BDI-II scores may have arisen from between-group differences in perceived 




were able to determine the study’s aim of preventing the emergence of depression 
symptoms, given that the intervention centered on the utilization of antidepressant 
strategies. Thus, treatment group participants may have felt that they should report 
less depression at the follow-ups, a reporting bias which could have been more of a 
factor during face-to-face (SCID) versus paper-and-pencil (BDI) assessments. 
Control group participants – who received no active intervention – had no such direct 
exposure to the study’s aims, and therefore faced much less in the way of a potential 
biasing influence of perceived social demand characteristics. 
It is also worth noting that the study researchers, due to limited resources, 
were not always effectively blinded to each participant’s assigned treatment group 
when performing follow-up SCID interviews (e.g., because the same researcher often 
led the participant’s group-based intervention and then later conducted the SCID).  
Thus, it is possible that inadvertent experimenter bias in conducting or interpreting 
the SCID may have played some role in influencing the study interview-based 
outcomes. 
Ongoing questions remain regarding the fact that the TLC intervention 
appeared to be moderately effective in changing some behaviors (fish oil intake, sleep 
habits, utilization of social support) but not others (sunlight exposure, anti-
rumination, exercise). With such a brief intervention, it is encouraging that any 
behavioral changes took place in an at-risk population. Future research, however, 
might look at what is needed to elicit significant, enduring change across all six 




such a treatment goal is even attainable.  Perhaps, for example, it would prove useful 
to provide participants with high-quality written take-home material – or internet-
based resources – to provide further explication and review of the intervention’s 
content.  
It is also unclear why some targeted preventive strategies were found to be 
unrelated to depression risk, despite previously published evidence of their 
prophylactic benefit. Sunlight exposure and fish oil supplementation, for example, did 
not emerge as significant protective factors in any of the risk analyses performed – 
despite the fact that treatment group participants were significantly more adherent to 
fish oil than were control group participants. The lack of significant findings for 
sunlight exposure could conceivably be due to the fact that many of the participants in 
this study already get a sufficient amount of sunlight as college students on a largely 
outdoor campus.  (At baseline, the mean adherence to sunlight exposure targets was 
79.98%.) Therefore, the truncated range of reported sunlight adherence in this 
population may not have allowed enough variation to detect a significant impact on 
depression risk. Similarly, the range for fish oil supplementation was also truncated, 
albeit at the low end of the continuum. The mean fish oil adherence in the treatment 
group was only 25.69% at two months and 27.14% at six months. While this was 
significantly greater adherence than that observed in the control group, it represents 
only about 1.5 fish oil pills per day, whereas the most widely accepted therapeutic 
dose is approximately 6 pills per day (Ilardi et al., 2009) required to meet the 1,000 





This study followed participants for six months. However, it remains 
unknown how effectively patients might maintain behavioral changes over even 
longer periods of time, or to what extent the implementation of TLC strategies would 
provide preventive benefit over time among high-risk individuals if they were 
maintained. 
Another key limitation of this study is the fact that the control condition 
included only an initial assessment – it did not include an intervention of any kind 
(e.g., an attentional control or a supportive group session). It is possible that this 
between-group procedural discrepancy introduced important participant differences in 
perceived demand characteristics of the study, inasmuch as treatment group 
participants likely ascertained the aim of the study based on the anti-depressant slant 
of the intervention, whereas control group participants had no such access to 
information about what the study was about. 
It should also be noted that while TLC is conceptually distinct from existing 
psychotherapies for depression, there are also areas of overlap (Karwoski, 2006). For 
example, TLC’s approach to stopping rumination – a behavior clearly related to 
depression risk, as seen in this study’s results – is based to a large extent on 
behavioral activation, which is included in the CT protocol (Beck et al., 1979). 
However, the behavioral activation strategies of TLC address the process of negative 
or ruminative thinking, whereas CT maintains a primary focus on the content of the 




social support is related to IPT’s central focus on the immediate social context (Frank 
& Spanier, 1995). However, social support strategies of TLC focus principally on 
enhancing the frequency and quality of social interactions, rather than the more 
detailed and nuanced IPT approach to interpersonal dynamics. TLC is primarily a 
behavioral therapy that is unique for its explicit integration of multiple biological 
approaches to depression prevention.  
Future Directions 
This study represents an initial look at TLC as prevention for depression. 
Future research should focus on clarifying the efficacy of each TLC element, and 
disentangling the aforementioned cause-and-effect issues between adherence to TLC 
and the experience of depression symptomatology. Also, it would be useful to 
determine why the study intervention was capable of inducing at least some increased 
adherence to target goals regarding fish oil supplementation, healthy sleep, and 
utilization of social support, but not to TLC elements such as exercise, sunlight 
exposure, and anti-ruminative activity. 
Perhaps the most exciting potential future direction is the utilization of a 
similar psychoeducational program with considerably larger at-risk populations. 
Preventive interventions are almost nonexistent in most communities (Muñoz, 1998), 
despite the fact that the prevention of depression provides much greater benefits to 
society and to individuals than does the treatment of one depressed individual at a 
time (Ingram et al., 2004). It is crucial, therefore, for clinicians to identify groups at 




target population, for example, would be individuals terminating psychotherapy or 
pharmacotherapy due to the experience of depression remission. Further, because 
college students, as a group, face a high level of depression vulnerability (Furr, 
Westefeld, McConnell, & Jenkins, 2001; Vredenburg, Flett, & Krames, 1993), and 
given the recommendation of the National Mental Health Association that colleges 
and universities would benefit from programs for prevention and early detection of 
depression (Field, Elliott, & Korn, 2006), a brief intervention such as TLC might be 
appropriate at a freshman orientation meeting or resident hall presentation. 
It would also be quite useful to see a replication of the present study with a 
non-college participant sample. College students are in some ways an ideal sample 
for a depression prevention study, given that: (a) more than half of depressed 
individuals will experience their initial episode by age 25 (Sorenson, Rutter, & 
Aneshensel, 1991); (b) college students are almost by default under unusual and 
heightened stress; and (c) being in one’s teens or twenties is regarded as a de facto 
risk factor for the onset of depression (Lewinsohn et al., 1988). However, Coyne 
(1996) points out potential problems with an excessive reliance on college students in 
the investigation of depressive illness. He argues that many people will have their 
initial episode after the typical college age, that college students are often distressed 
in the absence of clinical depression, and that the gender skew, high intelligence, high 
socioeconomic status, and underrepresentation of minorities on college campuses are 




In conclusion, TLC represents a set of specific lifestyle changes integrated 
into a novel intervention for depression, predicated on the idea that the higher rates of 
MDD today are a result of a mismatch between the modern environment and the 
environment for which humans are best adapted (Ilardi et al., 2009). Each of these 
lifestyle elements has been independently demonstrated to protect against the onset 
and/or reoccurrence of MDD, and TLC has already been successfully used as a 
treatment for acute depression (Ilardi et al., 2007; Karwoski, 2007). In this 
preliminary study of the use of TLC as prevention, healthy lifestyle factors were 
presented to participants in a one-hour group psychoeducational session. Participants 
in the treatment group experienced a significant reduction in the subsequent onset of 
depression in comparison with a non-treatment control group. They also reported 
increased adherence to fish oil supplementation and healthy sleep goals. Accordingly, 
TLC appears to have some promise as a low-cost, time-efficient alternative – or 
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Appendix A:  TLC Adherence Questionnaire 
 
LIFESTYLE QUESTIONNAIRE 
Your name: ________________________ 
KU ID: ___________________________ 
Date: _____________________________ 
 
Instructions:  Please think back over the past three months. On average, how much have 
you been doing the following things? 
 
On average… 
…how many hours of sleep have you been getting per night?  _______ 
…how many hours a day have you spent doing homework? _______ 
…how many academic credits have you been enrolled in? _______ 
…how many minutes of bright sunlight have you been getting per day? _______ 
…how many hours have you spent doing cardio exercise per week? _______ 
…how many pleasurable, fun activities have you engaged in per week? _______ 
…how many social activities have you engaged in per week? _______ 
…how many non-academic books have you read per month? _______ 
…how many times have you been eating out at a restaurant per week? _______ 
…how many minutes have you spent ruminating (thinking negatively) per day? ____ 
...how many hours have you spent in the presence of friends or other people you care 






Instructions:  Please circle the answer that best corresponds to your current practices.  
 
Do you take a daily multivitamin?  Yes  No  Sometimes 
 If so, what is your daily dosage? _______ 
Do you take a Vitamin E supplement?  Yes   No   Sometimes 
 If so, what is your daily dosage? _______ 
Do you take a melatonin supplement?   Yes   No   Sometimes 
 If so, what is your daily dosage? _______ 
Do you take a Vitamin A supplement?   Yes   No   Sometimes 
 If so, what is your daily dosage? _______ 
Do you take prescription allergy medicine?  Yes   No   Sometimes 
 If so, what brand(s) do you take? _______ 
Do you take an omega-3 (fish oil) supplement?    Yes   No   Sometimes 
 If so, how many pills do you take daily? _______ 
 If so, what is your daily dosage of EPA? _______ 
 If so, what is your daily dosage of DHA? _______ 
Do you take a birth control pill?   Yes   No   Sometimes 
 If so, what brand do you take? _______ 









• The purpose of this group is to spend one hour discussing depression and new ways 
that have emerged to prevent depression. 
• Rules 
o Your only job during this session is to listen attentively. You may also want 
to take some notes on the things we discuss. 
o You will not be required to share any personal information with the group, 
and you can remain completely silent if you like. 
o Everything in this group is completely confidential. I will not share any 
information shared by anyone with anybody else. I ask the same of each of 
you: do not share anything you hear with anyone outside of this group. This 
is important so that we can establish a comfortable environment in which 
we can discuss some important topics. Please nod now if you agree. 
• We will be discussing how to prevent depression from occurring and we will 
describe specific ways you can prevent the onset of a depressive episode. 
o This will include lifestyle changes that research shows help people ward of 
depression. 
 
Risk factors for depression 
• There are two important things that put people at risk for lapsing into depression: 1) 
previous depression; 2) current mild depression. 
• Previous depression as a risk factor 
o Depression is a recurrent disorder 
o Most people with depression will experience more than one depressive 
episode, averaging 4-5 major episodes over a lifetime. 
o Each episode makes it increasingly difficult to recover. 
o Preventing a second episode is especially important. Those who can prevent 
a second episode after having their first episode have a much better chance 
of recovering for life. 
• Mild depression as a risk factor 
o Severe depression is often preceded by mild depression. 
o Mild depression is painful and debilitating in and of itself. 
o Mild depression predicts the onset of a severe episode. 
o If you find ways to incorporate the lifestyle changes I describe to you today, 







High rates of depression 
 
• Rates of depression are skyrocketing and becoming quite prevalent in our society. 
There is almost a 20% lifetime risk: one out of every five people in the U.S. will 
suffer from depression at some time in their lives. 
o This is true despite the fact that so many people use antidepressant 
medications. 
• It hasn’t always been like this. So why are people more depressed now? Why are we 
seeing an epidemic of depression? We believe that the world we live in has qualities 
that are toxic to many people’s mental health and actually contribute to depression. 
o The modern human’s body and mind was not designed for life in 2009, but 
for an earlier period in human history! 
• Consider life in the 1800s. Most people lived on farms, doing lots of physical labor. 
They had to walk everywhere, spent lots of time outside, lived with many family 
members for their whole lives. 
• Now, think back a few thousand years. People used to live in a world that looks 
nothing like today’s! But this is the world the human body and the human mind are 
really designed for. The modern American environment may have characteristics 
that actually increase our risk for depression. 
• The huge mismatch between early and modern environments explains the increase 
in risk for depression. 
 
Ancestral vs. modern life 
• [Can elicit suggestions from participants if they choose to contribute] 
• Physical activity 
o Used to be necessary for survival – hunting, gathering, building shelter. 
Heavy lifting and fast running were daily activities. 
o Most modern jobs require us to be indoors; college requires you to be in 
class and inside studying. 
o We don’t even need to walk much if we don’t want to! 
• Nutrition/Diet 
• Sunshine 
o Most activities required people to be outdoors. All work had to be done 
outside. 
o Now, we miss out on a lot of sunlight. We can stay inside all day if we want. 
 
• Social contact 
o Used to be that people were virtually never alone. You were constantly 
surrounded by people who are related to you. 
o Now, many people live alone or with only one other person. 
o Our typical hobbies include TV, video games, and other non-social activities. 
o People often move away from family and friends (especially college 
students). 




o All dark hours were spent sleeping; if anything, people got too much sleep. 
o The average American gets less than 7 hours of sleep 
• So, it’s obvious that our lifestyles have changed a whole lot. And it’s tempting to 
think that all of our technological and social changes are good – and in many ways, 
they are! I would rather live in this century than 10,000 years ago! But a lot of the 
changes make it more likely for us to be depressed. 
o We have to work harder at it these days to stay away from depression. 
Today’s session 
• The strategies we will teach you today focus on changing aspects of our daily 
routines and lifestyles. 
o Each of these lifestyle changes has been supported by research studies and 
have  been shown to help reduce or eliminate depression. 
• There are some modern ways of dealing with depression, such as anti-depressants 
and traditional talk therapy. These can also be valuable. But we will show you some 
strategies that have no side effects, often cost nothing, and are good for your 
overall health. 
• If you are interested in doing this, you should have a really good chance of 
succeeding after this session, and some things you can start doing today! 
 
Omega-3 
• You probably know that our diets today are not healthy in general. One thing we are 
going to focus on today is to make sure you are getting the nutrients that are the 
most important in preventing depression. 
• You may or may not have heard about omega-3 fatty acids. This is a substance that 
is essential in proper brain functioning. 
• It comes from natural plants, and humans usually get it through eating animals that 
feed on these natural plants. People used to get it through eating fish and cattle 
that eat natural plants. But now, the meat and fish you get at the store are raised 
using artificial means and don’t eat those natural plants anymore. So people don’t 
get anywhere close to the right amount of omega-3 fatty acids in their diet. 
• So why are omega-3 fatty acids so important? They have antidepressant properties 
just like Paxil, Zoloft, and Prozac. This is because they help the brain work more 
efficiently, and they enhance brain processing in areas that control some aspects of 
depression. In fact, omega-3s work on the same brain circuits that antidepressants 
do. 
o Specifically, omega-3s help circuits that function using serotonin and 
dopamine in the brain. These are two chemicals related to depression. They 
tend to be low in people who are depressed, so certain brain circuits don’t 
work as well. The omega-3s help those circuits perform their function 
better. 
• Research studies now show that people taking a specific dose of omega-3 had a 
great improvement and mood and a decrease in depression symptoms. They even 




• Specifically, you will need 1000 mg of a certain version of omega-3: EPA. You can 
buy omega-3 pills at any pharmacy or drugstore like Walgreens, Target, or the Merc. 
You need to look on the back of the bottle and find the information on EPA. You 
should take however many pills are needed to add up to 1000 mg of EPA per day. 
This is usually about pills per day. 
• It is good if you take a multivitamin. This will help your body digest the omega-3 so 
that your body will get the most out of it. Any normal multivitamin will do. 
 
Light Exposure 
• We spend very little time outside. 
• Have you heard of people who get depressed or moody during the winter, and 
bounce back once spring comes around? 
o SAD tells us something about the relationship between light and mood, 
even for people who don’t have it. 
o It’s not the cold, or the snow. It’s actually the level of light: daylight gets 
shorter, the sun is not as high in the sky, and we get less light. 
o Same kind of feeling when there is really bad weather and you just don’t 
feel like getting out of bed. It’s normal to feel down when there is poor 
light. 
o That’s why bright light helps our mood. 
• Light is also related to the circadian rhythm, which is a cycle that controls bodily 
functions like sleeping and waking. It resets our internal clocks so that we follow a 
24-hour cycle. 
o When the circadian rhythm gets out of sync, we mess up our sleep cycle and 
sleep too much or too little. But we can readjust it if we expose ourselves to 
bright light. 
o This is true even for people whose mood is not affected by light. 
• What is bright light?…light is measured in “lux”. A sunny day is about 10,000 lux, 
compared to about 1,000 lux on a cloudy day. Normal indoor lighting is only 500 lux 
and does not provide an adequate amount of light. 
o Studies show that depressive mood diminishes if participants spend at least 
one hour per day at 3,000 lux. But 10,000 lux provides the most benefit. 
o It’s very important to be consistent and to get light at the same time every 
day. 
o For people who stay up late and sleep in, morning light is better. For people 
who go to bed early and get up early, evening light is better. 
• A good goal is to get at least 60 minutes of bright light every day. 
• Getting light outdoors 
o Can combine with exercise 
o Must be on a moderately bright day, in the middle of the day 
• Getting light from a light box 
o If you can’t be outdoors, or it’s winter and there are few sunny days, you 
may choose to get light from an artificial source. 




o Don’t look directly at the box, put it to the side, within two feet 
o Can read, eat, or watch TV 
• Remember, indoor light doesn’t work! However, sitting near a window at home or 
while driving is better than nothing. 
 
Exercise 
• One of the big symptoms of depression is a lack of energy. 
• Energy level is directly related to how much activity you want to engage in. Engaging 
in regular activity is like presetting your brain for a higher level of energy. Your brain 
keeps track of how much energy you use, and then gives you that amount of energy 
to use the next day. 
o If you don’t exercise, you have no energy, which leaves you susceptible for 
developing depression. 
• There is little demand for physical activity in our daily lives. In fact, people don’t 
need to exercise anymore, ever, if they don’t want to. So, purposefully engaging in a 
regular exercise program is the only way to get this antidepressant benefit. 
• Research using exercise to treat depression finds that it works just as well, or even 
better, than antidepressant medications! 
o There is a clinic in California that treats depression with exercise alone, no 
medications at all, and the rate of recovery is very high. 
• So, you probably already knew that exercise is good for you. Not exactly breaking 
news. But did you know it can prevent depression? And who really gets regular, 
vigorous exercise, at least 3 times per week? Not many of us. 
• The optimal level for mental health is about 35 minutes of aerobic/cardio exercise, 3 
times per week. 
o You may not exercise at all right now, which is okay. 
o This is a do-able goal that you can build up to over time. 
• Aerobic exercise is anything that keeps your heart rate up to about 120-160 beats 
per minute. What are some options? 
• [Demonstrate how to take heart rate.] 
 
Anti-rumination Strategies 
• Rumination is worrying or stressing out about something, dwelling on little things, 
mentally replaying things that didn’t go the way you wanted, worrying about the 
future. This is thinking about the same negative thought over and over without 
being able to come up with a solution or move on. It’s almost like a tape of negative 
statements playing in your mind. 
• You might have something normal but disappointing happen, like getting a bad 
grade or rejection by a friend…or it might be something that hasn’t even happened, 
like something in the future. But you tend to ruminate over what has gone wrong or 
what could go wrong. 
o This is not the helpful kind of thinking where you solve problems and make 




• Dwelling on these thoughts has a snowball effect, so that you start feeling more and 
more bad or guilty – maybe even guilty for spending too much time thinking! 
• This style of thinking makes you much more likely to get depressed. It’s like wearing 
dark-colored glasses. And the worse your rumination is, the more likely you are to 
get depressed and stay depressed. 
• The first step is to notice when you are doing it! It’s very easy to get caught in the 
habit of ruminating and not even be aware that you do it. It can be a way of life. So 
you need to step back and notice when you ruminate. Then you can take steps to 
stop it. 
• How to stop rumination 
o Schedule fun/pleasurable activities. When you notice you are ruminating, 
think, “I am ruminating and I should immediately get involved in an 
activity.” Pleasurable activities actually light up a part of the brain that 
counteracts depression (the left frontal cortex). Try to think of some 
activities right now that you could use. Try to think of at least 3 fun things 
you could do for yourself this week. Any ideas? 
 Don’t feel guilty about doing fun and pleasant things for yourself. 
They can keep you from getting depressed. 




• One of the most unfortunate side effects of depression is social isolation. Social 
activities are fun and positive. But when you are depressed, you might not feel like 
doing much except going to class. 
• When do people feel the most depressed? – often, at night, when they are alone. 
• Being around other people makes us feel better, even when we are not feeling 
sociable! When we are depressed, sometimes we worry about being a burden to 
others, or we prioritize other things (like school) over socializing. 
• When you don’t have a social support network in place, you are vulnerable to 
getting depressed! 
o Being with other people gives us someone to talk to about our problems – 
but it also distracts us, and helps us get our mind off our problems. 
o We automatically feel better just being around other people, feeling loved 
and cared for by others, laughing and being social. 
• People are designed to be social. 
o Just look at kids who are raised without social contact! 
o People used to spend virtually every moment with other people. They spent 
almost zero time alone. They used to live in villages with all their extended 
family near by. How many of you live in the same town as your parents? 
o Being alone during most of human history was a time to panic, because it 
was dangerous. You could literally die from being alone. So, depression and 
anxiety are natural reactions to being alone too much. 




• So how do you increase your social contacts? 
o Spend as much time with other people as possible – literally, all day. 
 Do it even when you don’t feel like it. 
o Think about people that are important to you that are far away. Would it 
help to reconnect with them over the phone and talk for half an hour or so? 
o Who lives around here that you can spend more time with? 
o If you don’t have anyone close to you here, think about ways to enhance 
your connectedness with people around you. Is there someone living in your 
hall that you could invite to coffee or a movie, or to study together? 
 
Sleep Hygiene 
• Lots of research has shown that when we don’t get enough sleep, our mood goes 
down the next day…or that when we are really well-rested, our mood is better. 
• 8 hour rule: on average, we really do need at least 8 hours of sleep. 
o The problem is, most of us don’t get 8 hours. Our lifestyles have gotten very 
busy. Many of us stay up late watching TV or surfing the internet. 
o The average number of sleep Americans get has decreased from 9 hours in 
1900 to less than 7 today! 
 There was no choice but to sleep, before electricity. 
 Our bodies are designed to get tired when it gets dark, but now we 
can distract from that with activities. 
• How do you know if you’re getting enough sleep?  If you are drowsy during the 
day, especially during boring lectures or other times you are understimulated. 
o This is actually sleep deprivation. 
• Other parts of this program that improve sleep 
o Exercise (but be sure not to do it 4 hours before bedtime) 
o Bright light – stabilizes sleep-wake schedule 
o Omega-3s can help 
• Get ready for bed. 
o Think about putting a two-year-old to bed. You can’t just stop playing and 
get them straight to sleep. You set up the environment: put on PJs, wash up, 
turn off the lights, read a quiet story. 
o It’s the same for adults. Create a ritual for yourself. 
 Turn down the thermostat. People sleep better when it’s colder. 
 Turn off bright indoor lights about an hour before bed. 
 Read a book (either fun or school), take a warm bath, listen to soft 
music 
 Avoid screens (TV/internet) 
• One of the biggest problems people have is getting impatient and upset if they can’t 
fall asleep 
o It’s like ruminating about not sleeping 
o An important thing to remember is to not lie down and try to sleep if you’re 
not tired. And if you lie in bed for awhile and can’t fall asleep, get up and do 
something quiet and relaxing until you’re tired. 




• Don’t do anything in bed except sleep (and maybe have sex)! No reading in bed, no 
phone calls, no TV. This way when you get into bed, your body knows it’s time to 
sleep. 
• Try to keep a regular sleep schedule 
o Go to bed at the same time every night and wake up at the same time every 
morning. No naps during the day. 
o This is really difficult to do in college – but it really makes a difference. 
o It’s tough to get up on days that you don’t have to. What are some ways to 
motivate yourself to get up? 
• Caffeine: avoid coffee, soda, energy drinks, chocolate, etc. before bedtime 
• Food: don’t go to bed hungry, but don’t go to bed really full; this makes it hard to 
sleep. 
• Alcohol: it’s a myth that alcohol helps you sleep. Sometimes it can help you fall 
asleep, but then it makes you restless and causes you to wake up. It also makes you 
dehydrated or have to pee frequently. Avoid alcohol within 4 hours of bedtime. 
• Try to be really tired by the time you go to bed – no naps, exercise, etc. 
• Consider wearing earplugs if your roommate or other noises wake you up. 
• Sleep deprivation is probably the BIGGEST trigger for the recurrence of depression. 










Three times a week, get 35 minutes of aerobic exercise. Aerobic exercise is anything 
that gets your heart rate elevated to about 120-160 beats per minute. Activities can include 
things like running, walking fast, biking, or playing basketball. 
 Anaerobic exercise (like yoga or weightlifting) is better than nothing, but the 
strongest antidepressant effects have been observed from aerobic exercise. Lots of people 
report that finding a regular exercise partner and routine helps them stay motivated. 
  
Omega-3 fatty acid (fish oil) supplements 
 
You can buy these at a grocery store, drugstore, or health food store (like 
Walgreens, Target, the Merc, etc.). Look for a brand that will give you at least 1000 mg of 
EPA per day. You will have to take about six pills every day to get this amount, which has 
been shown in studies to be beneficial to people with depression. Don’t forget to take a 
multivitamin, too. 
You can take these even if you are on antidepressant medication; there are no 
known interactions with drugs. The only side effect people have reported is that they 
sometimes burp up a fishy taste after taking them. Solutions to this problem are to freeze 




This strategy is most effective for people who notice that there is a seasonal 
component to their depression, but it can be helpful for everyone.  We recommend that 
people get at least 60 minutes of bright light exposure per day. The best way to do this is to 
actually go outside in the sun (take off the sunglasses, but leave on the sunscreen!). This 
works best on sunny days. 
Or, you can get light exposure from a special light box that emits the same amount 
of light (10,000 lux). You can try www.LightTherapyProducts.com to order a light box; a 
good one costs around $175. 
You should try to get light exposure at the same time every day. And don’t miss a 
day of light exposure if you can help it. This is something that will only work for you 




Rumination is the habit that many depressed people get into of dwelling on their 
negative thoughts. Rather than coming up with a solution to a problem and acting on it, 
people with depression often let their negative thoughts spiral out of control. It is important 




makes your mood worse and does nothing to actually help you. When you find yourself 
doing it, do one of these things: call a friend, take a walk outside, exercise, write down the 
negative thoughts in a journal, or do some other pleasant activity (like knitting, reading, or 




You have probably noticed that as you get more depressed, you are less motivated 
to seek out others for socializing. You must try to spend as much time as possible with 
others, even when you don’t feel like it. You should have at least two social contacts per 
week. This is a powerful way to distract yourself from rumination and get you the support 





You need to get at least 7 or 8 hours of sleep per night. One of the biggest risk 
factors for depression is sleep deprivation. Go to sleep and wake up at the same time every 
night. Prepare yourself for bed by having a “bedtime ritual.” About an hour before bedtime, 
dim the lights, turn off the TV and computer, put on your PJs, and do a quiet activity like 
reading. Avoid caffeine and alcohol for several hours before you plan to go to bed.  
 
 
*Remember: even though these strategies seem like just common sense, each of them has 
been shown to be effective in rigorous scientific studies. To prevent the onset of depression, 
try to maintain each of these lifestyle habits as best you can. If you feel yourself starting to 












What is my current lifestyle like? 
 
 
I exercise _______ times per week for _______ minutes. 
 
I take _______ mg of EPA omega-3 per day. 
 
I get _______ minutes of bright sunlight per day. 
 
I spend _______ minutes ruminating per day. 
 
I spend _______ hours around other people per day. 
 
On average, I get _______ hours of sleep per night. 
What are my goals for this semester? 
 
 
To exercise _______ times per week for _______ minutes. 
 
To take _______ mg of EPA omega-3 per day. 
 
To get _______ minutes of bright sunlight per day. 
 
To spend _______ minutes ruminating per day. 
 
To spend _______ hours around other people per day. 
 
On average, to get _______ hours of sleep per night. 
